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CHAPTER I 
 
INTRODUCTION AND RESEARCH GOALS 
 
Global Amphibian Declines 
 
In recent years, amphibian populations around the world have been suffering 
significant declines and some species extinctions.  Data collected from the United States, 
Puerto Rico, and Australia showed massive die-offs beginning in about the 1970s 
(27,54,103).  In the next decade, amphibian declines were well documented in Central 
America and South America (111,136,137,202).  Loss of amphibian populations was 
seen in populated areas as well as those that were considered uninhabited by humans 
(27,54).  By the 1990’s amphibian declines were recognized as a worldwide problem 
(37).  These declines have been attributed to a variety of factors including the commercial 
use of amphibians, the introduction of non-native species, destruction of habitats, climate 
change, environmental chemicals, and infectious diseases. 
 
Commercial use 
 
 Amphibians are used as a food source in many different countries.  A recent 
report (177) revealed four major conclusions about the frog leg trade: 1) 95% of the 
world demand is supplied by wild populations.  2) The international trade of frog legs 
involves 30 countries and was valued at 49 million dollars in 1998.  3) The supply burden 
for frog legs falls on 11 species.  4) The average amount of frogs harvested annually from 
1987 to 1997 was estimated to be 4,716 metric tons without including data from two 
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large frog leg exporting countries, China and Vietnam.  It was reported that 15 million 
frogs that were imported and declared wild were used as pets or food from 1998 to 2002 
(163).  Over time, collecting this large volume of animals can deplete wild stocks (38). 
 
Non-native species 
 
 Introduction of non-native species can cause amphibian declines or even 
extinctions in a direct or indirect manner in three ways.  First, non-native species prey on 
amphibian species at both the tadpole and adult stage of the life cycle, decreasing the 
overall population.  This predation most commonly occurs due to introduced fish, which 
feed on the eggs of amphibian populations.  Secondly, native species and non-native 
species compete for the limited resources of the habitat.  The third way by which non-
native species affect amphibian populations is when non-native species interbreed with 
native species, which in turn, can cause the loss of the native species (37).  A specific 
example of a non-native species introduction that led to amphibian declines is the case of 
the Mountain yellow-legged frog, Rana muscosa.  R. mucosa were plentiful in the high 
elevation lakes of the Sierra Mountains, but they declined rapidly after the lakes were 
stocked with trout.  When predatory fish were removed from some lakes, the R. mucosa 
populations recovered.  Evidence was presented that the fish preyed on the R. mucosa 
tadpoles (188).  In addition, the introduction of bullfrogs (Rana catesbeiana) and 
mosquitofish caused declines in the California red-legged frog (Rana aurora draytonii) 
(82,104,172). 
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Destruction of habitats 
 The destruction of habitats can lead to amphibian declines through human 
interventions that result in a change in land type (120).  Canadian studies show that 
deforestation and wetland drainage reduced the amphibian biodiversity from 13 species 
to 3 species in southwestern Ontario (82).  This finding suggests that a change in human 
land use or land type selected for the surviving species (37,172).  Rainforests also house a 
large amount of amphibian biodiversity, but they are being lost from slash and burn 
farming with other rainforest land area being converted to other land types due to climate 
change (2).  Amphibian species unable to adapt to the new habitats would have to be 
relocated or face die-offs. 
 
Climate change 
 The world’s climate is constantly changing.  Two factors, temperature change and 
precipitation change, have been shown to have some correlation with amphibian declines.  
A study from Costa Rica examined the decline and extinctions in the Atelopus genus and 
concluded that increased cloud cover and misting conditions caused stability between day 
and night temperatures.  These steady conditions favored the growth of the pathogen B. 
dendrobatidis and are referred to as the chytrid thermal optimum hypothesis (136).  
Several groups challenged the chytrid thermal optimum hypothesis citing the introduction 
of B. dendrobatidis and spread into naïve hosts as the most likely explanations of the 
declines (38,109,149,189,192).  Because amphibians are ectothermic organisms, 
temperature can have profound effect on immunity and breeding patterns (28).  Overall it 
is very difficult to prove that any of these factors is solely responsible for amphibian 
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declines.  It is much more reasonable that they are working in concert to have a 
detrimental impact on amphibians (38). 
 
Environmental chemicals 
 Pesticides, herbicides, and fertilizers all fall under the category of environmental 
chemicals.  Amphibians are thought to serve as environmental sentinels because large 
impacts on an ecosystem are first experienced by these animals.  Although pesticides are 
important for protecting vital crops from insects, these chemicals can seep into aquatic 
habitats following rains.  These compounds can also lead to growth deficiencies and limb 
abnormalities (14).  Industrial pollution has increased the environmental concentrations 
of heavy metals, and acidification of water sources has had detrimental effects on 
amphibian populations to the point of extinction (79,105).  Environmental contaminants 
may affect the reproductive system indirectly by altering the endocrine system.  The 
herbicide atrazine is reported to cause male frogs to be feminized and hermaphroditic 
(80).  Environmental contaminants can cause elevated corticosterone levels that in turn 
lower reproduction (65,86).  Pesticides carried upwind have been suggested to be the 
cause of some amphibian declines in regions of California (48). 
 
Emerging infectious diseases 
 Emerging infectious diseases are a growing concern as previously pristine areas 
have suffered major amphibian declines (30).  Ranaviruses, double-stranded DNA 
viruses, infect a variety of aquatic animals including amphibians, reptiles, and fish (47).  
Ranaviruses have been suggested as a cause for declines in North America, South 
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America, Australia, and Europe (15,43,44,47,52,92,205).  Although these viruses did 
cause mortality through systemic hemorrhage or skin ulceration, there is not much 
evidence to suggest that ranaviruses or another suspected pathogen, Aeromonas 
hydrophila, are responsible for extinctions (44,47).  The leading pathogen linked to 
amphibian declines, however, is the fungus Batrachochytrium dendrobatidis. 
 
Batrachochytrium dendrobatidis 
 Batrachochytrium dendrobatidis was first isolated from a blue poison dart frog, 
Dendrobates azureus (114).  B. dendrobatidis is in the phylum chytridiomycota and is the 
only member of the phylum that is pathogenic to vertebrates (84,90,91).  Although it is 
unknown where the pathogen originated, the most reasonable hypothesis is that it spread 
out of Africa or Asia (5,190).  The two life stages of B. dendrobatidis are the immature 
zoospore and the mature zoosporangium.  The flagellated zoospore is motile for about 24 
hours in which it must find a suitable substrate or die (9,114,185).  When an amphibian 
host is found, the zoospore resorbs its flagellum and moves into the protective 
intracellular environment of the skin cells.  Here, the zoospore develops a thallus and 
thread-like rhizoids and further matures into a zoosporangium.  Within the 
zoosporangium, new zoospores differentiate.  The new zoospores can be released through 
a discharge tube as the skin reaches the surface, and then can re-infect the same 
individual at a different site or a different individual. The entire life cycle takes 
approximately 4-5 days at the optimal growth temperature of 22°C (Fig 1-1) (9,185,192). 
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Figure 1-1.  B. dendrobatidis life cycle.  At the optimal growth temperature of 22°C it 
takes 4-5 days to complete the B. dendrobatidis life cycle (192). 
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Chytridiomycosis and B. dendrobatidis pathogenesis  
 Amphibians infected with B. dendrobatidis may develop clinical signs of the 
disease and die or, depending on their level of resistance, may remain relatively 
unharmed.  The disease caused by B. dendrobatidis is called chytridiomycosis.  The 
clinical signs observed after infection include excessive skin sloughing, skin reddening, 
loss of appetite, loss of righting reflex, lethargy, and abnormal posture (184,185,187).  It 
has been postulated that the excessive skin sloughing is an adaptation to skin infections 
and is not directly initiated by the pathogen itself (184).  The mechanism by which B. 
dendrobatidis kills amphibians is not well understood.  The leading hypothesis is that 
colonization of the skin interferes with transport of essential ions from the environment 
and the amphibian (184,187).  Amphibians with chronic infections have decreased 
calcium, potassium, and sodium concentrations in the blood compared to uninfected 
individuals and eventually succumb to asystolic cardiac arrest (184,186,187).   
 Because amphibians are ectothermic animals, temperature can have a drastic 
impact on their immunity to B. dendrobatidis.  B. dendrobatidis thrives at temperatures 
ranging from 17-23°C (135,192).  B. dendrobatidis cannot tolerate temperatures above 30 
°C (136).  Extreme low temperatures (7-10°C) slow maturation, but zoospores are still 
infectious (192).  Field studies support the idea that temperature affects immunity to B. 
dendrobatidis.  Amphibians found at lower temperatures had a higher prevalence of B. 
dendrobatidis compared to amphibians found at higher temperatures (194).  Lower 
temperatures were also associated with more frequent population die-offs (11). 
 Not all amphibians are susceptible to chytridiomycosis.  Xenopus laevis is 
relatively resistant with only 3% prevalence in wild populations (190).  These finding 
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were recapitulated in the captive setting.  Captive X. laevis did not show any clinical 
signs of infection (130).  On the other hand some amphibian species, such as Bufo 
boreas, are very susceptible to chytridiomycosis.  This species has suffered significant 
declines during the 1970s-1980s (29,31).  Experimentally B. boreas can be exposed to as 
few as 10,000 zoospores for 1 day and the exposure results in 100% mortality (29).   
 
Innate immunity and skin AMPs 
 The skin is the largest organ in the human body and serves as a physical and 
chemical barrier against microbes.  The skin serves as a physical barrier by tightly joining 
the keratinocytes with desmosomes, impeding the infiltration of microbes (42,139).  
Components of the chemical barrier in the skin are cytokines, the complement cascade, 
leukocytes, and AMPs. 
 
Skin AMPs 
 The cell responsible for making a majority of the AMPs in human skin is the 
keratinocyte, which constitutively produces low levels of AMPs to control microbial 
colonization (61).  After AMPs are synthesized and packaged into lamellar bodies in the 
stratum granulosum, they are transported to the stratum corneum (1).  Another rich 
source of AMPs in the skin are sebocytes, mast cells, and neutrophils (61).  Secretions 
such as saliva and sweat have been shown to contain AMPs (12). 
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AMPs and infection 
 Following an injury to the skin, keratinocytes increase AMP production.  AMPs 
have chemotaxic properties and recruit neutrophils, mast cells, and leukocytes to the site 
of infection as another source of AMPs (61).  The invading pathogens can in turn trigger 
the transcription of AMPs through Toll-like receptor signaling (12).  TLR stimulation 
serves a secondary response when the constitutive expression of AMPs from the 
keratinocytes fails (61). 
 
Skin AMPs specically target microbes 
 Microbial surfaces of Gram-postive and Gram-negative bacteria have negatively-
charged phospholipids and are naturally attracted to the overall positive charge of AMPs 
(93).  Viral and fungal surfaces have negatively-charged components (93).  After 
insertion into the lipid bilayer the cell membrane becomes unstable, and the cell is killed 
by lysis (83).  Recent evidence has shown AMPs have the ability target bacteria 
undergoing cellular division (99). 
 
Overview of fungal immunity 
 Fungi are eukaryotic organisms, and animals are exposed to them on a daily basis.  
Despite encountering potentially infectious fungal species frequently, most fungi do not 
cause disease unless they infect immunocompromised individuals (24).  The worldwide 
prevalence of dermatological fungal infections (skin, nails, and mucosa) is estimated to 
be approximately 25% (24).  Although fungal infections are rarely invasive, cryptococcal 
meningitis, disseminated candidiasis, and invasive pulmonary aspergillosis still have a 
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30-80% mortality rate during treatment and 100% mortality if untreated (24).  The innate 
immune cells (macrophages and neutrophils) are considered to be central to an effective 
recognition of fungal pathogens.  However, effective immunity also requires adaptive T-
cell mediated responses (24,25)  These points will be described in greater detail in the 
subsequent paragraphs. 
 
Pattern recognition receptors and fungal immunity 
 Pattern recognition receptors can be grouped into four families: Toll-like 
receptors (TLRs), Nod-like receptors (NLRs), RIG-I-like receptors (RLRs), and C-type 
lectin receptors (CLRs).  All four of these families recognize pathogens, but only TLRs 
and CLRs contribute directly to fungal immunity.  MyD88 is an important signaling 
molecule in the TLR signal transduction pathways.  Mice lacking this signaling molecule 
showed increased susceptibility to the fungal pathogens Candida albicans, 
Paracoccidioides brasiliensis, Aspergillus fumigatus and Cryptococcus neoformans 
(18,25).  Specific TLRs that have been implicated in recognizing fungi are TLR1, TLR2, 
TLR4, TLR6, TLR7, and TLR9 (18,25).  The specific role of TLRs is in fungal immunity 
is controversial.  Mice infected with different isolates of C. albicans showed varying 
results of TLR participation (124).  In addition, humans that lacked MyD88 but were 
immunocompetent did not show a predisposition to fungal diseases (13). 
 
CLRs and fungal immunity 
 CLRs are the family of patter recognition receptors that are critical for fungal 
immunity.  CLRs are characterized by having a C-type lectin domain.  They exist as 
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soluble and transmembrane proteins and have been shown to bind to most disease-
causing fungi (204).  CLRs bind specifically to fungal cell wall carbohydrates (123).  The 
three major components of the fungal cell wall are mannan, β-glucan, and chitin (123).  
Dectin-2, mannose receptor, C-type lectin receptor DC-SIGN and Mincle bind structures 
found in the mannan layer, and Dectin-1 binds β-glucan (55).  After binding to fungal 
structures, these receptors are able to trigger a number of responses such as phagocytosis, 
and the induction of anti-fungal mediators, which will be discussed in further detail in the 
next section. 
 
Signal transduction by CLRs  
 When activated, Dectin-1, Dectin-2, and Mincle induce intracellular signaling 
through tyrosine-based activation motifs that are able to recruit and activate Syk kinase.  
Syk kinase is able to activate proteins including MAP kinase, NFAT, and NF-κB 
(69,73,107,161,173).  Dectin-1 and DC-SIGN can also activate NF-κB through the Raf1 
pathway (71,72).  Mice lacking CLRs or the downstream signaling components have 
defective immunity against fungal pathogens (45,73,148,159,160,173,176,200).  Human 
polymorphisms in CLRs have been shown to increase susceptibility to fungal infections 
(58).  Each CLR can recognize a variety of fungal pathogens, but it is suspected that there 
is some overlap.  On the other hand, there is evidence of specificity; Dectin-1 can only 
recognize β-glucans in the yeast form of Candida because in the other forms 
(pseudohyphae and hyphae) mannan blocks exposure (63).   
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CLRs and the adaptive response 
 Macrophages and neutrophils have been identified as critical cell types in 
antifungal immunity (24,25).  Loss of macrophages or neutrophils or impairment has 
been shown to increase susceptibility to fungal infections (25).  Activation of CLRs 
moderate effector functions and trigger the inflammatory response (55).  Dectin-1 
activation has been show to produce a respiratory burst, inflammatory mediators, 
cytokines (TNF, IL-1β, IL-6, and IL-23), and chemokines (CCL2, CXCL1, and CCL3) 
(55,175,181).  When mice deficient in Dectin-1 were infected with C. albicans and A. 
fumigatus, they were unable to control fungal growth and also showed impairment in 
neutrophil and monocyte recruitment and production of IL-6 (176,191). 
 CLR signaling can induce TH1 and TH17 responses, and it has been shown that 
the TH17 responses play a critical role in the antifungal immune response (3).  TH1 
responses are able to control systemic fungal infections by activating phagocytes through 
IFN-γ.  TH17 responses are essential for the mucosal immune response against fungi 
(41).  A number of defects in TH17 responses have led to increased susceptibility to 
fungal infections including mutations in IL-17, IL-17RA, STAT1, and STAT3 
(112,140,183).  Although the exact mechanism of how TH17 responses direct immunity 
at the mucosa is still undetermined, it is thought that IL-17 mediated neutrophil 
recruitment and IL-22-mediated production of antimicrobial peptides in the epithelial 
cells play important roles (41). 
 CLR signaling can also stimulate adaptive immunity against fungal pathogens.  
After CLRs recognize fungi, the pathogen is phagocytosed and killed by phagocytes 
triggering TH1 and TH17 responses.  CLR-mediated signaling induces IL-12 production 
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by antigen presenting cells, which in turn can drive IFN-γ production by iNKT cells and 
TH1 cells activating more phagocytes (36,72).  Through CLR-mediated signaling, 
antigen presenting cells can also produce the cytokines IL-1β, IL-6, and IL-23 creating an 
environment encouraging TH17 differentiation (107).  The differentiated TH17 cells are 
able to produce IL-22, which drives AMP production of epithelial cells and IL-17, which 
recruits neutrophils (41). 
 
Antimicrobial peptides 
 Antimicrobial peptides (AMPs) are an evolutionarily conserved innate immune 
defense.  AMPs are a diverse and abundant set of molecules that are found in a variety of 
tissues and cell types in bacteria, invertebrates, plants, and animals (203).  AMPs have 
been shown to have activity against a range of pathogens including bacteria, fungi, 
viruses, and protozoa (203).  AMPs can be grouped based on sequence and structure into 
anionic peptides, linear cationic α-helical peptides, cationic peptides enriched for specific 
amino acids, and anionic and cationic peptides that contain cysteine and form disulfide 
bonds (23). 
 
Anionic peptides 
 Anionic peptides are small negatively-charged peptides rich in glutamic and 
aspartic acids and range from about 721.6-823.8 Da.  This group of AMPs is commonly 
found in bronchoalveolar fluid and airway epithelial cells (21,22).  Specific members of 
this group of AMPs are dermicidin from humans and maximin H5 from amphibians 
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(101,162).  This group of AMPs require zinc as a cofactor for antimicrobial activity and 
have activity against Gram-positive and Gram-negative bacteria (21,22). 
 
Linear cationic α-helical peptides 
 This second group of AMPs contain less than 40 amino acids and lack cysteine 
residues (66,180).  In the presence of aqueous solutions, these peptides appear disordered 
through their circular dichroism, but adopt an α-helical conformation in micelles and 
vesicles (66,94).  Members of this group include mellitin from insects, magainin from 
amphibians and LL-37 from humans (23).  When adopting the α-helical conformation, 
this group has activity against Gram-positive and Gram-negative bacteria (129). 
 
Cationic peptides enriched for specific amino acids 
 AMPs abaecin and drosocin from honeybees and Drosophila respectively belong 
to this group for their high abundance of proline and arginine residues (15).  This group 
also contains the bactenecin family of peptides found in cattle, sheep, and goats and PR-
39 from pigs, which have high amounts of proline (33-49%) and arginine (13-33%) 
residues (66,127).  Humans express small histidine-rich salivary polypeptides (96).  
These peptides lack cysteine residues. 
 
Anionic and cationic peptides that contain cysteine and form disulfide bonds 
 The key characteristics of this group are the presence of cysteine residues, the 
formation of disulfide bonds, and stable β-sheets.  The brevinin and ranatuerin AMP 
families from ranid frogs belong to this particular group of AMPs because they each 
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contain one disulfide bond (7).  The α- and β-defensins found in humans belong to this 
group.  They contain three disulfide bonds and are conserved in rats, rabbits, mice, cattle, 
pigs, goats, and poultry (106)  Of particular note are the AMPs in this group that have 
antifungal properties such as drosomycin from Drosophila and plant antifungal defensins 
in addition to the brevinin and ranatuerin families (7,57). 
 
AMP attachment 
 Many AMPs are attracted and bind to the bacterial membrane due to the anionic 
and cationic binding properties of the peptides and the cell surface molecules.  Many of 
the molecules on Gram-negative bacteria, such as lipopolysaccharide, and Gram-positive 
bacteria, such teichoic acids are negatively charged.  In vitro studies have determined that 
α-helical peptides and β-sheet peptides embed into the lipid head group which stretches 
the membrane (33).  For other peptides interacting with membranes, such as magainin-2, 
the stress of the membrane is minimal (116). 
 
AMPs and membrane insertion 
 Membrane insertion is governed by the peptide to lipid ratio.  At low peptide to 
lipid ratios, peptides are oriented parallel to the membrane; however, as more peptides 
bind and the peptide lipid ratio increases the peptides reorganize into a perpendicular 
orientation eventually inserting into the membrane (201).  After a membrane insertion, a 
number of models have been proposed to explain membrane permeabilization. 
 In the “barrel-stave model,” helical peptides arrange themselves in a bundle 
forming a pore (201).  The hydrophobic residues of the AMPs bind to the lipid core and 
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the hydrophilic residues are on the inside of the pore.  The amount of peptides needed for 
pore formation ranges from 3-11 peptides with diameters ranging from 1.8 nm-4.0 nm 
(81,170).  This model so far has only been supported by the AMP alamethicin. 
 The next model is called the “carpet model” because peptides continue to bind to 
the anionic phospholipid head group in a parallel fashion (138).  After a high number of 
peptides are bound to membrane, the peptides disrupt the bilayer and form micelles 
similar to the action of a detergent (100,165).  As a result, transient holes form, 
increasing exposure of the bilayer to AMPs and the eventual disintegration of the bilayer.  
This model is supported for the mechanism of the peptide dermaseptin (138). 
 In the last model, called the “toroidal-pore model,” helices aggregate and cause 
the lipid monolayers to bend in on themselves forming a pore (117).  This bending causes 
the two leaflets to become one because the peptides still only associate with the head 
groups of the bilayer (117).  This particular model differs from the barrel-stave model 
because the peptides never dissociate from the polar head groups (201).  The hydrophobic 
regions are bound to the membrane while the hydrophilic regions form the inner part of 
the pore.  Magainin-2 appears to function by this mechanism of action (117). 
 
Amphibian AMPs 
 One of the important dermal glands in amphibian skin is the granular gland 
(Figure 1-2) (19).  The primary role of the granular gland is to synthesize defensive 
peptides including AMPs and then package and store them into secretory granules (53).  
The granular gland is surrounded by myoepithelial cells that contract following a signal 
from the α-adrenergic receptor.  This action pushes the granules through the duct lumen 
 17 
and onto the surface of the skin.  After secretion, these AMPs that are present in the 
mucus layer are thought to provide a protective barrier against potential pathogens.  We 
and others have hypothesized that antimicrobial skin peptides may play a role in 
protection of amphibians from skin pathogens.  The focus of my research was the 
investigation of the role of antimicrobial peptides (AMPs) produced in granular glands of 
the skin in defense against chytridiomycosis. 
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Figure 1-2.  The amphibian granular gland.  Amphibian granular glands synthesize 
defensive peptides including AMPs and secrete them onto the surface of the skin (115).  
This image was modified from Dockray and Hopkins (53). 
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Research Goals 
 Because B. dendrobatidis colonizes the skin, AMPs that are stored in the granular 
glands of the skin may play a role in B. dendrobatidis resistance.  The goal of this 
research was to investigate the role of AMPs in the skin secretions of northern leopard 
frogs (Rana pipiens) in protection against the fungal pathogen B. dendrobatidis.  The 
goals of my research are listed below. 
1) To determine if AMPs were detectable on the skin of resting and active frogs.  It 
was previously thought that proteases from the host or resident skin microbiota would 
rapidly digest AMPs before they could act effectively.  Using MALDI-TOF MS and 
growth inhibition assays, I evaluated the presence and activity of AMPs from resting and 
active frogs.  The pattern of skin peptides and effectiveness in resting and active was 
compared to frogs injected with norepinephrine to induce peptide release. 
2) To evaluate the rate of loss of AMPs on the skin following secretion. R. pipiens 
were injected with norepinephrine to induce AMP secretion.  Secretions remained on the 
skin for 0, 15, 30, 60, and 120 minutes before being washed off the animal.  Expression 
of AMPs over time was examined using MALDI-TOF, and activity was examined using 
growth inhibition assays.  MALDI-TOF MS profiles was examined for peptide cleavage 
products.  In addition the relative concentration of individual AMPs was quantified over 
time by “spiking” samples with a known amount of an alkylated peptide standard. 
3) To determine the role of AMPs in protecting R. pipiens from B. dendrobatidis 
infection.  For these experiments, frogs were injected with increasing concentrations of 
norepinephrine to determine the necessary dose for AMP depletion.  Next, B. 
dendrobatidis naïve juvenile R. pipiens were depleted of AMPs and experimentally 
 20 
infected with B. dendrobatidis.  Frogs were monitored for zoospore load and mortality.  
Controls included uninfected animals and peptide-intact animals. 
4) To develop a better way for monitoring B. dendrobatidis infection status.  The 
typical method for quantifying pathogen load on infected amphibians is to swab animals 
on the most infected areas including the ventral abdomen, legs and footpads.  Although 
this method is optimal for the field, the main drawback is that it does not take into 
account the pathogen load on the whole animal.  A new method was developed to take in 
to consideration the entire skin surface of the frog.  In this method a frog was placed in a 
finite volume of sterile water.  After a short time, the frog was removed, and the water 
was filtered.  The filter was treated to extract DNA and qPCR was performed.  This 
method was tested side-by-side with accepted methods of measuring infection status. 
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CHAPTER II 
 
THE EBB AND FLOW OF ANTIMICROBIAL PEPTIDES ON THE SKIN OF 
RANA PIPIENS 
 
 Abstract  
Many amphibian species are threatened with extinction by the emerging 
infectious disease, chytridiomycosis, caused by the fungus Batrachochytrium 
dendrobatidis.  This unprecedented global crisis threatens to reduce the biodiversity of 
the entire amphibian class.  The fungus invades the skin and impairs the uptake and 
retention of essential ions leading to cardiac arrest.  Antimicrobial peptides (AMPs) 
secreted into the mucus of some amphibians are thought to be an important defense 
against chytridiomycosis.  However, little is known about the quantities of AMPs 
secreted under natural conditions, whether they are sufficient to protect against this 
pathogen, and how they interact with commensal microbes.  To understand how 
defensive peptides and skin microbes may interact, it is essential to know the precise 
quantities of AMPs present under natural conditions.  Using matrix-assisted laser 
desorption time-of-flight mass spectrometry and growth inhibition assays, we show that 
northern leopard frogs (Rana pipiens) at rest constitutively release low amounts of AMPs 
that inhibit B. dendrobatidis in vitro, and AMP defenses are elevated following a 
simulated predator attack.  Using a synthetic peptide analogue of brevinin-1Pb as an 
external control, we quantified the amounts of four previously described AMPs (brevinin 
1Pa, brevinin-1Pb, brevinin-1Pd, and ranatuerin-2P) at several time points after secretion.  
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Once secreted onto the skin, the peptides are most active for 15 min, and small quantities 
persist for at least 2 h.  Taken together, our data suggest that small amounts of AMPs are 
rapidly available and quite stable on the skin of R. pipiens.  They are effective inhibitors 
of B. dendrobatidis at these low constitutive concentrations but degrade within 2 h, 
protecting the integrity of the skin and commensal bacteria. 
 
Introduction 
 Antimicrobial peptides (AMPs) are produced by a diverse array of organisms 
including plants, insects, and vertebrates (203).  Their presence in so many species 
suggests that they play a fundamental role in the innate defense of each species against 
microbial pathogens.  However, whether they provide a ‘constitutive’ defense critical for 
survival or an ‘induced’ defense is somewhat controversial (40,75).  The skin of many 
amphibians is a rich source of AMPs (40,157,203).  If AMPs are part of the constitutive 
barrier defense against pathogenic organisms in amphibians, it is expected that the 
concentrations secreted would be sufficient to inhibit pathogens, but beneficial symbiotic 
microbes would be tolerant of the same concentrations of the peptides.  The emerging 
infectious disease, chytridiomycosis, caused by Batrachochytrium dendrobatidis, 
continues to cause massive amphibian population declines and extinctions in many parts 
of the world (10,17,108,114,134,142); reviewed in (30,98,168).  This loss of amphibian 
species will reduce the biodiversity of many ecosystems in which amphibians play an 
important role (168,174).  While it is well known that amphibian populations vary in their 
susceptibility to chytridiomycosis (10,110,146,196–198), the reasons for this variability 
are not well understood.  We hypothesize that AMPs synthesized and stored in the 
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granular glands of the skin of many species are an important innate defense against B. 
dendrobatidis.  The pathogen is spread by water-borne flagellated zoospores that settle on 
the frog, enter the cells of the stratum granulosum of adult skin, and replicate in the 
protected environment of the host cells.  The zoospores mature into zoosporangia that 
release new zoospores able to re-infect the same individual at a different site or a new 
host (9,10,114,134,185).  Thus, initial infection and re-infection would require that 
zoospores overcome chemical defenses, including AMPs, in the mucus.  Some amphibian 
species are resistant to severe B. dendrobatidis infections, but other, more susceptible 
species, succumb to lethal chytridiomycosis (10,108,196–198).  Present evidence 
suggests that death due to severe chytridiomycosis results from disruption of the skin and 
failure to maintain a balance of essential ions (184,187).  Previous studies have shown a 
good correlation between the in vitro effectiveness of skin peptides against B. 
dendrobatidis and the survival of amphibian species in the wild or when experimentally 
infected (157,196–198).  Other studies have described a variety of skin bacteria isolated 
from B. dendrobatidis-resistant hosts that inhibit growth of the pathogen (195,199) and 
can protect young frogs from chytridiomycosis when the skin is bioaugmented with 
protective bacteria (78).  Thus, many species of beneficial bacteria persist in the mucus 
where AMPs would be secreted.  Although AMPs have been isolated from skin 
secretions of many amphibian species, there is little information about the availability of 
these peptides on the skin of undisturbed resting frogs or naturally active frogs.  The 
central questions addressed by this study are whether a suite of natural AMPs can be 
detected in resting and active frogs and are they inhibitory to B. dendrobatidis at these 
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constitutive concentrations.  Once secreted onto the skin, how stable are the peptides and 
how long are they effective? 
 
Materials and Methods 
 
Frogs 
Rana pipiens measuring between 2 and 2.5 inches were purchased from 
Connecticut Valley Biological (Southampton, MA, USA).  Frogs were housed in groups 
of 5 or 6 in covered polystyrene containers in dechlorinated tap water at a temperature of 
20–24 °C.  Containers were placed at an incline, allowing the frogs to choose a wet or dry 
area.  They were fed live crickets, and their water was changed three times weekly.  All 
protocols were approved by the Vanderbilt University Medical Center Institutional 
Animal Care and Use Committee. 
 
Peptide collection and quantification 
To collect AMPs from the skin, frogs were injected in the dorsal lymph sac with 
amphibian phosphate buffered saline (APBS; 6.6 g NaCl, 1.15 g Na2HPO4, and 0.2 g 
KH2PO4 per 1 liter distilled water) or norepinephrine-HCl (Sigma, St. Louis, MO, USA) 
dissolved in APBS and were placed in collection buffer for 15 min (Figure 2-1).  After 
the frog was removed, the buffer was acidified, and the peptides were enriched by 
passage over C18-Sep-Paks (Waters Corporation, Milford, MA, USA).  The eluted 
peptides were quantified using the microBCA assay, concentrated by centrifugation 
under vacuum, and resuspended in HPLC water at a known concentration. 
 25 
To collect skin secretions from resting frogs, they were placed directly into 
collection buffer without norepinephrine injection.  Frogs that were given a simulated 
‘alarm’ stress were removed from their holding tank, rinsed with clean water, placed in 
the dry container, and chased in a large polypropylene box for 5 min.  The investigator 
reached in with a gloved hand and forced each frog to move around the box for 5 min, 
and then the frog was placed in collection buffer for an additional 10 min while the 
peptides accumulated.  Peptides were concentrated and quantified as described above. 
The weight of each frog was determined at the time of peptide collection, and 
total peptides were quantified.  To estimate the amount of peptides in mucus, the surface 
area of the skin was determined according to the method of McClanahan and Baldwin 
[Surface area = 9.9 (weight in grams)
0.56
] (119).  We assumed the thickness of the mucus 
to be 50 µm (26), and therefore the volume of mucus covering one cm
2
 of skin would be 
5 µl. One ml (1000 µl) = 5 µl X 200.  Thus, total peptides (µg) per cm
2
 X 200 = total µg 
ml
-1 
in mucus. 
To determine the stability of AMPs on the skin, frogs were induced to secrete 
peptides by injection of APBS or norepinephrine.  The secretions remained on the skin of 
norepinephrine-injected frogs for 0, 15, 30, 60, or 120 min before they were washed off 
by immersion in collection buffer, enriched over C-18 Sep-Paks, and quantified.  For the 
0-time point, frogs were injected with norepinephrine and immersed in collection buffer 
within 10 s of injection. 
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Figure 2-1.  Peptide collection protocol.  The stimulus applied to the frog is either, 
chasing with a gloved hand or injecting with norepinephrine or APBS. 
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Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass 
spectrometry (MS) 
Following partial purification, the recovered peptides were concentrated to 
dryness by centrifugation under vacuum at 70 °C, resuspended in HPLC-grade water at 1 
mg ml
-1
, mixed with α-Cyano-4-hydroxycinnamic acid matrix (CHCA) (LaserBio Labs, 
Sophia-Antipolis, France) and spotted onto the target plate.  MALDI-TOF MS was 
performed using a Bruker Daltonics Ultraflex III time-of-flight mass spectrometer 
(Billerica, MA, USA) operated in reflector, delayed extraction and positive ion mode.  
The instrument was calibrated using a mixture of standard peptides including leucine 
enkephalin with a mass to charge ratio (m/z) of 556.277, human angiotensin II (m/z 
1046.542), human [Glu1]-fibrinopeptide B (m/z  1570.677), and bovine oxidized insulin 
chain B (m/z 3494.651).  Spectra were acquired from 500 to 5,000 m/z ratio range.  
Automated data acquisition was performed by averaging 250 laser shots. 
For direct MALDI-TOF analysis, carbon embedded film (Goodfellow Cambridge 
Ltd., Cambridge, England) was cut into 1 cm squares and activated by dipping in 100% 
methanol (Figure 2-2) (199).  After air drying, the film was applied to the frog for 10 s on 
each side of the frog.  Film was attached to a sample plate with electrically conductive 
adhesive transfer tape (3M Co., St. Paul, MN, USA), spotted with CHCA, and mass 
signals collected as described above. 
To determine the relative intensity of each peptide in a sample at a given time 
point, we added a synthetic external standard peptide, cys-iodoacetamide-modified 
brevinin-1Pb (1.25 nM), in which the two cysteine residues were alkylated.  The 
sequence and mass to charge ratio of the modified peptide is 
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FLPIIAGIAAKVFPKIFCAISKKC, m/z 2693.30.  The mass of modified brevinin-1Pb is 
shifted by 117.9 mass units in the MALDI-TOF profiles.  For each peptide the relative 
intensity in arbitrary units was compared to the relative intensity of alkylated brevinin-
1Pb in the same sample, and the ratios for all of the samples were averaged. 
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Figure 2-2.  Direct MALDI-TOF protocol.  Using this method, skin peptides can be 
sampled directly and detected without purification. 
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Growth inhibition assays 
Briefly, freshly isolated B. dendrobatidis zoospores (isolate JEL 197) were plated 
(5 X 10
4
/50 µl) in 1% tryptone broth with 50 µl of a serially diluted mixture of skin 
peptides.  Positive control wells (no peptide addition) contained zoospores and 50 µl of 
HPLC water.  Negative control wells contained 50 µl of heat-killed zoospores (60 °C, 10 
min) and 50 µl of HPLC water.  Plates were incubated at 23 °C for 1 week and growth 
was measured as an increase in optical density at 490 nm (OD490).  For most peptide 
inhibition assays, we determined a minimal inhibitory concentration (MIC) defined as the 
lowest concentration of peptides at which no growth could be observed.  Relative peptide 
effectiveness is percent inhibition of each sample at a concentration of 12.5 µg ml
-1
 
multiplied by the total peptides recovered (µg ml
-1 
of mucus). 
 
Statistical comparisons 
All parameters compared in this study (B. dendrobatidis growth as OD490, peptide 
concentrations as µg ml
-1
 of mucus, relative intensity of peptide signals in comparison 
with alkylated brevinin-1Pb, and relative peptide effectiveness) were averaged and the 
mean values ± standard errors were compared by a one-tailed or two-tailed Student’s t-
test or one-way ANOVA with planned comparisons and Tukey post hoc tests as indicated 
in figure legends.  Peptide concentrations, OD values, and relative peptide effectiveness 
values were log transformed as indicated in figure legends to meet the assumptions of 
normal distribution and homogeneity of variances for parametric statistics.  A P-value of 
≤ 0.05 was considered to be statistically significant. Error bars shown in all figures 
represent standard errors.  If no error bar is visible, the standard error was less than the 
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diameter of the symbol.  In B. dendrobatidis growth inhibition assays, each data point 
represents the mean ± standard error of five replicate wells.  For other parameters, the 
number of animals or samples is shown in the figure legends. 
 
Results 
 
Expression of AMPs in resting, chased, and norepinephrine induced frogs 
The MALDI-TOF MS profile of skin peptides in resting and chased frogs 
determined by direct sampling with carbon-embedded film in comparison with 
norepinephrine-injected frogs shows that both resting and active (chased) frogs express 
detectable amounts of several AMPs (brevinin-1Pa, brevinin-1Pb, brevinin-1Pd, and 
ranatuerin-2P) characteristic of frogs from the northeastern USA (178) (Fig. 2-3A-C).  
Comparison of the amount of total hydrophobic (C-18 enriched) skin peptides secreted by 
resting versus chased frogs shows that the amounts recovered from the chased frogs 
(6,411.2 ± 1,672.3 µg ml
-1
 of mucus) was significantly greater than that of the resting 
frogs (1,795.7 ± 266.8 µg ml
-1
 of mucus) (Fig. 2-3D).  The mixture of recovered skin 
peptides from both the resting frogs (Fig. 2-3E) and chased frogs (Fig. 2-1F) showed 
significant antimicrobial activity against B. dendrobatidis zoospores, but it was less than 
that observed when peptides were induced by norepinephrine (20 nmol/g) (Fig. 2-3G).  
The MICs for peptide samples from resting frogs ranged from 100 to >200 µg ml
-1
 (N = 
4); whereas those of peptides from chased frogs were 100–200 µg ml-1 (N = 4), and those 
of peptides from norepinephrine-induced frogs were usually 100 µg ml
-1
 or less (range 
25–250 µg ml-1, N = 9).  This suggests that both resting and chased frogs have significant 
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amounts of AMPs capable of inhibiting skin pathogens (178), but they express less than 
norepinephrine-injected frogs. 
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Figure 2-3.  MALDI-TOF profiles and B. dendrobatidis growth inhibition by skin 
peptides from resting, chased, and norepinephrine-stimulated frogs.  Representative 
skin peptides of (A) resting, (B) chased, and (C) norepinephrine-induced frogs.  The m/z 
for each antimicrobial peptides (AMP) is shown.  (D) Total hydrophobic peptides 
recovered from resting (N = 5) and chased (N = 5) frogs.  *Significantly greater than 
those of resting frog by two-tailed Student’s t-test after log transformation, P ≤ 0.05.  
Growth inhibition of B. dendrobatidis zoospores by skin secretions from (E) resting, (F) 
chased, and (G) norepinephrine-induced frogs (20 nmol/g).  *Growth was significantly 
less than that of positive control wells (N = 5 replicates) by two-tailed Student’s t-test 
after log transformation, P ≤ 0.05. 
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Stability of AMPs secreted onto the skin 
 Frogs were induced to secrete their peptides by injection of 20 nmol g
-1
 
norepinephrine, and the peptides were allowed to remain on the skin for various periods 
of time until the frogs were immersed in buffer to collect the peptides.  Total peptides 
recovered from secretions that had been left on the skin for 0 min (less than 10 s between 
injection of norepinephrine and immersion in buffer) or 15 min were not significantly 
different from each other, and the amounts were maximal at these time points (67,928 ± 
12,773 µg ml
-1
 of mucus at 0 min and 86,401 ± 11,957 µg ml
-1
 of mucus at 15 min).  
After 30 min on the skin, the total amount of peptides washed from the skin had 
decreased significantly from the amount recovered after 15 min on the skin, and the 
amounts of peptides recovered at 60 and 120 min after secretion were very low (11,336 ± 
2,037 µg ml
-1
 of mucus at 60 min and 5,265 ± 1,474 µg ml
-1
 of mucus at 120 min).  
Control frogs injected with APBS consistently secreted a very low concentration of 
peptides (1506 ± 146 µg ml
-1
 of mucus) (Fig. 2-4). 
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Figure 2-4.  Total peptide stability on the skin.  (A) Peptides recovered from frogs 
injected with amphibian phosphate buffered saline (APBS) (N=8) or 20 nmol/g 
norepinephrine (N = 28). Secretions remained on the skin of norepinephrine-injected 
frogs for 0, 15, 30, 60, and 120 min before collection (N = 5 or 6 samples at each time 
point).*Significantly less peptides in comparison with the amounts recovered at 15 min, 
P < 0.01;**Significantly less peptides in comparison with the amounts recovered at 0, 15, 
or 30 min, P ≤ 0.01 by one-way ANOVA after log transformation and Tukey post hoc test. 
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By MALDI-TOF MS, we examined the relative intensity of four AMPs in 
comparison with an external standard (a synthetic alkylated-brevinin-1Pb).  Shown in 
Figure 2-5, is the mechanism to alkylate the cysteine residues creating a mass shift to 
distinguish it from the native brevinin-1Pb.  The alkylated form was assessed for purity 
by diluting to a concentration of 100 nM and performing MALDI-TOF MS.  Next, the 
external standard was added to every peptide samples from the different time points.  
Shown in Figure 2-6A-B are representative plots from the 0 and 60 min time point.  The 
peak intensity of the external standard increases over time. 
The pattern of relative intensities for individual brevinin-1 peptides (brevinin-1Pa, 
brevinin-1Pb, and brevinin-1Pd) and ranatuerin-2P in comparison with the external 
standard showed that these peptide signals were most stable at 15 min on the skin.  
Although reduced in intensity, they remained quite stable for up to 60 min on the skin but 
were significantly reduced by 120 min on the skin (Figs. 2-7A-D). 
 Enriched peptide samples from the above time points were incubated with B. 
dendrobatidis zoospores to assess their activity in growth inhibition assays.  Peptides 
from the 0- and 15-min time points were strongly inhibitory.  The MICs for the 0-time 
point samples ranged from 25 to 250 µg ml
-1
 (average 69.4 µg ml
-1
).  One representative 
sample of peptides from the 15-min time point is plotted in Fig 2-8A.  Peptides from the 
30-min time point were less effective with an MIC of 50 µg ml
-1
 (one representative 
sample of peptides plotted in Fig 2-8A).  The peptides recovered at later time points did 
show some inhibition but failed to achieve an MIC at concentrations up to 500 µg ml
-1
.  
One representative of a sample of peptides collected at 60 min is plotted in Fig. 2-8A. 
 
 37 
 
 
Figure 2-5.  Mechanism of irreversibly alkylating cysteine residues and external 
standard purity.  (A) By treating with iodoethamide, cysteines become alkylated 
creating a mass shift and peak that is not normally present in R. pipiens skin peptide 
samples.  The alkylated form of brevinin-1Pb has a mass of 2693 m/z.  (B) The alkylated 
form of brevinin-1Pb was assessed for purity by MALDI-TOF MS. 
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Figure 2-6.  Representative MALDI-TOF MS profiles with the external standard at 
the 0 (A) and 60 (B) minute time points.  The peak of the external standard is boxed. 
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Figure 2-7.  Individual 
peptide stability.  (A-D) 
Relative peptide signal intensity 
(arbitrary units) of (A) brevinin-
1Pa, (B) brevinin-1Pb, (C) 
brevinin-1Pd, and (D) 
ranatuerin-2P in comparison 
with the external standard (1.25 
nM alkylated-brevinin-1Pb).  
*Significantly less than the 
signal intensity at 15 min by 
one-tailed Student’s t-test after 
log transformation, P ≤ 0.05. 
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Peptide effectiveness was calculated by multiplying the percent inhibition of each 
individual sample at 12.5 µg/ml by the total amount of peptides recovered at each time 
point. There was no significant difference in peptide effectiveness between the 0- and 15-
min time point, but the peptide effectiveness significantly decreased at the 30, 60, and 
120 min time points (Fig. 2-8B).  The peptide effectiveness of mixtures of peptides from 
resting and chased frogs is not shown here because there was no inhibition at 12.5 µg ml
-
1
. 
 
Detection of peptide fragmentation ions over time 
 To further understand the possible degradation of AMPs on the skin after 
secretion, we studied the MALDI-TOF peptide profiles of representative samples which 
remained on the skin for 60 or 120 min.  Not only did the signals for the intact peptides 
decrease in intensity, but a number of smaller peptide fragments that would be the 
expected products of proteolytic cleavage were detected at 60 and 120 min.  For example,  
at 60 and 120 min after secretion onto the skin, all of the brevinin-1P signals and the 
mass signal for ranatuerin-2P were reduced and peptide fragments of mass 752, 1139, 
1456, 1610, and 1972 could be detected (Table 2-1).  These fragments were absent from 
the time 0 samples.  The smaller peptide fragments would occur if a protease that cleaves  
at a position preceding lysine residues was released at the time of granular gland 
discharge.  These fragments can also be observed in the MALDI-TOF spectra of resting 
and chased frogs (Table 2-1). 
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Figure 2-8.  Inhibition of B. dendrobatidis growth by peptides recovered after 
various periods on the skin and peptide effectiveness.  (A) Growth inhibition by a 
representative sample of peptides collected after 15, 30, and 60 min on the skin.  The 
positive control was living zoospores in broth and the negative control was heat-killed 
zoospores in broth.  (B) Average peptide effectiveness of all samples (N = 5 or 6 at each 
time point except at 120 min N = 3 due to insufficient quantities to test in the remaining 
samples).  Peptide effectiveness is percent inhibition at a concentration of 12.5 µg ml
-1
 
multiplied by the total peptides recovered (µg ml
-1 
of mucus).*Significantly less effective 
than peptides on the skin for 15 min by two-tailed Student’s t-test, P ≤ 0.005 after log 
transformation. 
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Table 2-1.  Antimicrobial peptides and fragment ions detected by matrix-assisted 
laser desorption time-of-flight mass spectrometry. 
 
Peptide Sequence Monoisotopic mass 
(m/z) 
Observed 
mass in 
resting or 
chased  
Observed 
mass at 60 
or 120 
min 
Bradykinin RPPGFSPFR  1060 X X 
Brevinin-1Pa FLPIIAGVAAKVFPKIFCAISKKC  2563 X X 
Brevinin-1Pb  FLPIIAGIAAKVFPKIFCAISKKC  2577 X X 
Brevinin-1Pd FLIPIIASVAANVFSKIFCAISKKC  2569 X X 
Brevinin-1Pa or 
Brevinin-1Pb 
fragment 
KVFPKIFCAISKKC  1610 
 
X X 
Brevinin-1Pa, 
Brevinin-1Pb, 
or Brevinin-1Pd 
fragment 
KIFCAISKKC  1139 X X 
Brevinin-1Pb 
fragment 
FLPIIAGIAAKVFP  1456 X X 
Ranatuerin-2P GLMDTVKNVAKNLAGHMLDKL
KCKITGC  
3000 X X 
Ranatuerin-2P 
fragment  
KCKITGC  752 
 
X X 
Ranatuerin-2P 
fragment 
KNLAGHMLDKLKCKITGC  1972  X 
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Discussion 
 
Expression of AMPs in resting, chased, and norepinephrine-injected frogs 
 
 Our studies of the northern leopard frog, R. pipiens, address the fundamental 
question of whether AMPs secreted onto the skin of amphibians are constitutively 
secreted at concentrations sufficient to inhibit skin pathogens.  Using a very sensitive 
direct MALDI-TOF MS approach (32,199), as well as collection of skin washings, we 
show by MALDI-TOF MS analysis and growth inhibition assays that both resting frogs 
and chased frogs secrete detectable amounts of peptides that inhibit growth of B. 
dendrobatidis zoospores (Fig. 2-3).  Previously, it was unclear if the peptide mixture 
from resting frogs would show evidence of individual AMPs.  There was a concern that 
proteases on the skin would degrade AMPs too quickly for peptide activity to be detected 
on resting frogs (145,171).  However, when peptide mixtures from resting and chased 
frogs were tested for activity against B. dendrobatidis zoospores (the infectious stage of 
the B. dendrobatidis life cycle), the peptide mixtures from both were inhibitory.  The 
peptide mixtures from the chased frogs were somewhat more inhibitory than those from 
the resting frogs, but less effective than those from norepinephrine-induced frogs (Figs. 
2-3E-G).  The increased inhibition observed in samples from chased frogs may be due to 
a higher concentration of AMPs that have not been degraded by proteases.  We assume 
that most peptides present on the skin of resting frogs were secreted sometime in the 
previous 24 h and would be degraded by putative endogenous proteases secreted from 
granular glands (146,172) or by possible proteases secreted by microbiota resident on the 
skin (199).  In contrast, most of the peptides present on the skin after the frog was chased 
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would have been secreted within 15 min of their collection in buffer (5 min of the chase 
period and 10 min in the buffer).  Thus, they would have had much less time for exposure 
to proteases. 
 
Stability of AMPs secreted onto the skin 
Although individual peptides from R. pipiens have been shown to have growth 
inhibitory activity against B. dendrobatidis (151,178), the stability of the AMPs once 
secreted onto the skin has not previously been determined.  Our studies show that the 
greatest amount of recoverable peptides and the greatest inhibitory activity against B. 
dendrobatidis was observed in the first 15 min after secretion onto the skin (Figs 2-4 and 
2-8).  At later time points, the amount of peptides and antimicrobial activity declines until 
it is very low at 120 min after secretion onto the skin.  Proteases secreted by the frog 
(145,171) and possible proteases secreted by skin bacteria may degrade the peptides.  
Gradual loss of secreted AMPs may be necessary to protect beneficial symbiotic 
microbes (195,199). 
To determine if and when individual AMPs are being degraded, MALDI-TOF MS 
was performed on the secretions at different times after collection.  At the 0-min time 
point, the same AMPs are found as observed in the resting frog samples (Fig 2-6A).  
Brevinin-1Pa, brevinin-1Pb, brevinin-1Pd, bradykinin, and ranatuerin-2P were observed 
(Figs 2-6A).  When MALDI-TOF was performed on frog secretions that had been on the 
skin for 60 min, the relative intensities of the AMPs had decreased (Fig 2-6B).  Relative 
intensities for each AMP were compared to that of an external standard resulting in 
relative intensity ratios.  Compared to the external standard, the peptide signals detected 
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up to 60 min on the skin were quite stable for brevinin-1Pa, brevinin-1Pb, brevinin-1Pd, 
and ranatuerin-2P (Figs 2-7A-D). 
 
Detection of peptide fragmentation 
 Further evidence that the AMPs are being degraded is the presence of breakdown 
products.  A protease that cleaves at a position preceding lysine residues has been 
reported in skin secretions from Xenopus laevis (145).  At 60 and 120 min after secretion 
onto the skin, the MALDI-TOF profile shows peptide cleavage fragments expected for 
both families of peptides based on predicted mass (Table 2-1).  Additional evidence that 
the peptides are being degraded is shown by the decreased ability of samples that had 
been on the skin for a longer period to inhibit the growth of B. dendrobatidis zoospores.  
The longer the peptides were on the skin, the higher the concentration of peptides 
necessary to achieve complete inhibition of growth (Fig. 2-8A).  In an effort to further 
quantify the peptide activity, peptide effectiveness was calculated.  Peptide effectiveness 
is robust at 0 min, peaks after 15 min on the skin, and declines rapidly after 30 min (Fig. 
2-8B).  This finding suggests that the AMPs secreted onto the skin are highly effective 
for at least 15 min, and some activity persists for at least 2 h. 
Collectively, our studies show that northern leopard frogs constitutively secrete 
small amounts of antimicrobial skin peptides that increase with frog activity or simulated 
predator stress.  This may indicate a role for defensive peptides in wound repair or for 
deterrence of predators.  The concentrations are sufficient to inhibit growth of B. 
dendrobatidis zoospores and may be effective deterrents of B. dendrobatidis colonization 
of the skin.  Upon induction, the peptides are highly effective for at least 15 min on the 
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skin but degrade thereafter.  We suggest that the degradation of AMPs may be necessary 
to limit harm to beneficial symbiotic microbes on the skin.  Since R. pipiens is known to 
harbor B. dendrobatidis infections in the wild (128,192), constitutive AMP defenses may 
play a role in limiting the intensity of infection.  Ongoing studies will determine how 
AMP expression in amphibian skin responds to infection by B. dendrobatidis or other 
pathogens and how these AMP concentrations affect resident bacterial populations.  
These studies illustrate the value of northern leopard frogs as a model species to study the 
role of skin peptides in protection from B. dendrobatidis and other skin pathogens.  They 
strongly support a role for the constitutive expression of AMPs in defense of the skin.  
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CHAPTER III 
 
SKIN PEPTIDES PROTECT JUVENILE LEOPARD FROGS FROM 
CHYTRIDIOMYCOSIS 
 
Abstract 
 
One issue of great concern for the scientific community is the continuing loss of 
diverse amphibian species on a global scale.  Amphibian populations around the world 
are experiencing serious losses due to the chytrid fungus, Batrachochytrium 
dendrobatidis.  This pathogen colonizes the skin leading to disruption of ionic balance 
and eventual cardiac arrest.  In many species, antimicrobial peptides secreted into the 
mucus are thought to contribute to protection against colonization by skin pathogens.  
Although it is generally thought that antimicrobial peptides are an important component 
of innate immune defenses against B. dendrobatidis, much of the current evidence relies 
on correlations between effective antimicrobial peptide defenses and species survival.  
There have been few studies to directly demonstrate that antimicrobial peptides play a 
role.  Using the northern leopard frog, Rana pipiens, we show here that injection of 
norepinephrine brings about a long-term depletion of skin peptides (initial concentrations 
do not recover until after day 56).  When peptide stores recovered, the renewed peptides 
were similar in composition to the initial peptides by MALDI-TOF mass spectrometry 
and in activity against B. dendrobatidis determined by growth inhibition assays.  Newly 
metamorphosed froglets depleted of their peptide stores and exposed to B. dendrobatidis 
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died more rapidly than B. dendrobatidis-exposed froglets with their peptides intact. Thus, 
antimicrobial peptides in the skin mucus appear to provide some resistance to B. 
dendrobatidis infections, and it is important for biologists to recognize that this defense is 
especially important for newly metamorphosed frogs in which the adaptive immune 
system is still immature. 
 
Introduction 
 
Antimicrobial peptides (AMPs) are an important component of the innate immune 
system of vertebrates and play important roles as the first line of defense at mucosal 
barriers (76,203).  Like many other frog species, the skin of R. pipiens has two sets of 
distinctive glands (19,60).  Mucus glands produce a material rich in heavily glycosylated 
mucins (164) and mucopolysaccharides (56), which are continuously released to keep the 
skin moist.  AMPs and other defensive peptides are produced in granular glands (also 
called poison glands) within the dermal layer of the skin.  The contents of the granular 
glands empty into the thin layer of mucus produced independently by the mucus glands 
(62,154).  We recently showed that in R. pipiens, the AMPs are continuously released in 
low amounts and persist for several hours after release.  Thus, there appears to be a 
steady flow of low amounts of AMPs to deter skin pathogens (131). 
The skin of many amphibian species has been shown to produce a diverse array of 
AMPs that have activity against gram positive and gram negative bacteria, viruses, and 
fungi (126,141,157).  Each species has its own distinctive repertoire of AMPs (39).  The 
peptides are synthesized as precursor peptides with a signal sequence and an acidic 
 49 
propiece that are cleaved to release the mature active peptide before or at the time of 
secretion (4).  The peptides are tightly packed into the enveloped granules within the 
syncytial structure of the granular glands poised for release (19,126).  The glands are 
surrounded by a layer of myoepithelial cells innervated by sympathetic nerves (167).   
Following alarm or injury, the sympathetic nervous system is activated, neurotransmitters 
engage the adrenergic receptors (8,85), and the contents of the gland are released onto the 
surface of the skin (53).  When the glands are stimulated, the granules containing 
peptides are released in a what has been described as a “holocrine” fashion (53).  
However, this terminology suggests that the cell membranes of the producing cells are 
disrupted, and the entire contents are extruded.  Our own studies suggest that most 
physiological responses to normal stresses would result in release of some, but not all, of 
the contents of the glands; and the structure of the gland would persist to enable 
restoration of peptide synthesis (62,144).  Because the myoepithelial cells surrounding 
the glands have alpha-adrenergic receptors, they can be experimentally induced to release 
their contents by injection of norepinephrine (53).   
Worldwide amphibian declines and extinctions have been linked to an emerging 
infectious disease, chytridiomycosis, (38,168) which is caused by the fungus 
Batrachochytrium dendrobatidis (B. dendrobatidis) (10,114,134).  Because B. 
dendrobatidis colonizes the keratinized epithelium of the skin, we investigated the 
possible role of AMPs as a mechanism to provide some protection from infection by this 
pathogen.  Accumulating evidence suggests that AMPs released into the mucus provide 
the first line of defense against this pathogen (131,144,152,154,157).  Water -borne 
zoospores of B. dendrobatidis adhere to the skin, form a germination tube, and migrate 
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into the stratum granulosum to mature in the protected environment of the host cell (710).  
After maturing into a zoosporangium, a discharge papillus opens, and new zoospores 
move out to infect a new individual or the same individual at other sites (9,10,114,134).  
During infection or re-infection, zoospores would encounter the chemical defenses of the 
host mucus. Those defenses include AMPs, lysozymes, mucosal antibodies, and bacterial 
metabolites (154). 
B. dendrobatidis not only infects adult frogs but also colonizes the mouthparts of 
tadpoles (10,143).  When a tadpole undergoes metamorphosis, the newly developing 
adult-type skin provides an appropriate environment for B. dendrobatidis at the same 
time that the adaptive immune system is suppressed (154,156) and much of the 
organism’s energy is spent completing metamorphosis.  Metamorphosis is driven by the 
concerted actions of thyroid hormones and corticosteroid hormones (49,50).  The 
elevated corticosteroid hormones at metamorphosis induce apoptosis of thymocyte and 
splenocyte populations (6,150) resulting in a temporary suppression of immune responses 
during the climax of metamorphosis (156).  At the same time, the thyroid hormones drive 
differentiation of larval skin to the adult pattern of keratinized epithelium (121).  Only the 
keratinized epithelium of the tadpole mouthparts and the adult skin are colonized by B. 
dendrobatidis (10).    
In B. dendrobatidis-infected populations, metamorphosing frogs appear to be the 
most susceptible stage for infection (10,17,142,143,179,189).  Thus, we hypothesized 
that during the period around the time of metamorphosis, AMP defenses in the skin 
would be critical to provide some degree of protection against pathogens like B. 
dendrobatidis.  Here, we describe an experimental treatment to deplete skin peptides in 
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adults and metamorphosing juveniles and show that recovery of peptides is very slow 
after maximal depletion.   Recovered AMPs were identical in composition to previously 
secreted AMPs and retained activity against B. dendrobatidis.  Depletion of AMPs in 
newly metamorphosed juveniles negatively impacted survival following exposure to B. 
dendrobatidis. 
 
Materials and Methods 
 
Frogs 
Adult Rana pipiens measuring between 2 to 2.5 inches, were purchased from 
Connecticut Valley Biological Supply (Southampton, MA, USA).  Frogs were housed in 
groups of 5-6 in polystyrene containers measuring 17.5 x 9.5 x 8 inches containing 
dechlorinated tap water at 20-24°C.  Juvenile R. pipiens were reared to the age of 3-6 
months post-metamorphosis in chytrid-free conditions by T. L. C. from eggs provided by 
Nasco (Fort Atkinson, WI, USA) and transported to Vanderbilt University.  At 
Vanderbilt, these frogs were housed in groups in the same polystyrene containers used for 
adults.  For the B. dendrobatidis infection studies, the juveniles were housed individually 
in sterile 9 oz plastic Gladware® containers in dechlorinated tap water at 20-24°C.  
Containers were placed at an incline, allowing the frogs to choose a wet or dry area.  
Adults and juveniles were fed live crickets (pinhead crickets and mini mealworms for 
juveniles), and their water was changed three times weekly (adults) or five times weekly 
(juveniles).  All protocols were approved by the Vanderbilt University Medical Center 
Institutional Animal Care and Use Committee. 
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Determination of the dose of norepinephrine necessary to deplete skin peptides stores 
 
To determine the amount of norepinephrine necessary to maximally deplete skin 
peptides, groups of adult frogs were injected with 0 [N = 8], 2 [N = 8], 20 [N= 6], 40 [N= 
9], or 80 [N= 9] nmol/g of norepinephrine-HCl (Sigma, St. Louis, MO, USA) dissolved 
in amphibian phosphate buffered saline (APBS) as previously described (Chapter II).  
Peptides released into collection buffer were collected and quantified as described below. 
 
Kinetics of skin peptide renewal 
To determine the time necessary for recovery of skin peptides following 
norepinephrine-induced peptide-depletion, a large group of frogs was injected with 40 
nmol norepinephrine/g [N = 25] or 20 nmol norepinephrine/g [N = 26], and a subset of 
the animals was injected with the same dose at days 3, 10, 20, 30, 40, and 50 [N = 4 or 5 
at each time point].  Peptides were collected and quantified at each time point.  
 
Peptide collection, partial purification, and quantification 
 
Frogs were injected in the dorsal lymph sac with APBS or norepinephrine 
dissolved in APBS and placed in collection buffer for 15 minutes as previously described 
(Chapter II).  After 15 minutes, the frog was removed and the buffer was acidified by 
adding trifluoroacetic acid to a final concentration of 1%.  Peptides were partially 
enriched over C18 Sep-Paks (Waters Corporation, Milford, MA, USA) and quantified 
using the MicroBCA™ (bicinchonic acid) assay (Pierce, Rockford, IL, USA) according 
to manufacturer’s instructions except that the peptide bradykinin (RPPGFSPFR) (Sigma 
Chemical, St. Louis, MO, USA) was used as a standard (131,144,155).  The weight of 
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each frog was determined at the time of the injection, and total induced peptides were 
quantified.  To estimate the total amount of peptides recoverable in the mucus, the 
surface area was calculated according to the method of McClanahan and Baldwin (1969) 
[Surface area = 9.9 (weight in grams)
0.56
].  The thickness of the mucus was assumed to be 
50 µm (26), and therefore the volume of mucus covering one cm
2
 of skin would be 5 µl.  
As a result, the total peptides (µg) per cm
2
 X 200 = total µg/ml in mucus (131,144). 
 
Skin histology 
A section of dorsal skin, ventral skin, and the region of skin termed the dorsal 
plicae (19) from 3 peptide-depleted and 3 APBS-injected frogs was removed after 
euthanasia and fixed in 10% buffered formalin for 48 hours.  The skin sections were 
processed, embedded in paraffin, and stained with hematoxylin and eosin (H&E) by the 
Vanderbilt Immunohistochemistry Core in order to visualize granular glands.  
Approximately 10 sections from each skin sample (60 total) were examined.  Stained 
slides were photographed using an Olympus BX41 microscope with an Olympus DP71 
camera and DP Controller software, version 3.1.1.267 (Olympus Corporation, Center 
Valley, PA, USA). 
 
Matrix-assisted laser desorption time of flight (MALDI-TOF) mass spectrometry (MS) 
 
After partial purification, the recovered peptides were concentrated to dryness by 
centrifugation under vacuum at 70°C and prepared for MALDI-TOF analysis as 
previously described (Chapter II).  The peptides were resuspended at a concentration of 1 
mg/ml in in highly pure water suitable for high performance liquid chromatography 
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(HPLC), and a mixture containing 0.6 µl of resuspended peptides and 0.6 µl of α-Cyano-
4-hydroxycinnamic acid (CHCA) matrix (Sigma, St. Louis, MO, USA) was spotted onto 
the target plate and air-dried.  MALDI-TOF MS was performed using the Bruker 
Daltonics Ultraflex III time-of flight mass spectrometer (Billerica, MA, USA) operated in 
reflector, delayed extraction, and positive ion mode.  The instrument was calibrated using 
a mixture of standard peptides including leucine enkephalin with a mass to charge ratio 
(m/z) of 556.277, human angiotensin II (m/z 1046.542), human [Glu1]-fibrinopeptide B 
(m/z  1570.677), and bovine oxidized insulin chain B (m/z 3494.651).  Spectra were 
acquired from 500 to 5,000 m/z ratio range.  Automated data acquisition was performed 
by averaging 250 laser shots.  Samples from greater than 30 adult and 12 juvenile frogs 
were examined, and representative profiles are shown. 
 
Growth inhibition assays 
 
The growth inhibition assays were performed as previously described (Chapter 
II).  Briefly, B. dendrobatidis zoospores were grown on 1% tryptone agar for one week at 
23°C.  Freshly isolated zoospores were plated (5 x 10
4
/50 µl, 5 replicates for each 
concentration to be tested) in tryptone broth in a 96-well flat-bottom microtiter plates 
with 50 µl of a serially diluted mixture of skin peptides dissolved in HPLC-grade water.  
Positive control wells (5 replicates) contained zoospores and 50 µl HPLC water.  
Negative control wells (5 replicates) contained heat-killed zoospores (60°C for 10 
minutes) and 50 µl of HPLC water.  Plates were incubated at 23°C for one week, and 
growth was measured as an increased optical density at 490 nm (OD490) using an MRX 
Microplate Reader (Dynex Technologies, Inc., Chantilly, VA, USA).  Peptide 
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effectiveness was defined as the percent inhibition at a peptide concentration of 12.5 
µg/ml multiplied by the total amount of peptides recovered from the individual frog 
(131).  For the comparison of peptide effectiveness, growth inhibition was determined 
over a series of peptide concentrations for 5 frogs sampled at day 0 and 5 frogs sampled 
at day 3. 
 
Quantification of B. dendrobatidis zoospores on the skin 
Frogs were swabbed with a sterile cotton swab ten times on the abdomen, legs, 
and each foot according to established protocols (20,89).  Swabs were placed into tubes 
containing 60 µl of PrepMan Ultra (Applied Biosystems, Foster City, CA) and 30-35 mg 
zirconium/silica beads (0.5 mm in diameter) (Biospec Products, Bartlesville, OK).  
Swabs were homogenized in a Mini Beadbeater (MP Bio, Solon, OH for 45 seconds and 
then centrifuged for 15,000 X g for 30 seconds.  The homogenization and centrifugation 
steps were repeated once.  Next, samples were boiled for 10 minutes and cooled at room 
temperature for 2 minutes.  Samples were centrifuged at 15,000 X g for 3 minutes and the 
supernatants were removed for real-time PCR. 
Real-time probe-based PCR assay were performed on the Mx3000P Real-Time 
PCR system (Stratagene, La Jolla, CA).  The thermal profile was the default conditions 
(95°C for 10 minutes,95°C for 30 seconds, 55°C for 1 minute, and 72°C for 1 minute) for 
40 cycles.  A standard curve based on the cycle threshold (Ct) values from control 
zoospore DNA at known concentrations.  For this assay, there was a “no template 
control” containing all reaction components except the DNA template, a positive control 
containing DNA extracted from a swab loaded with a known number of zoospores, and a 
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negative control containing DNA extracted from a sterile swab.  All skin swab samples 
and controls were run in triplicate, and Ct values were averaged between the three wells. 
 
Exposure of post-metamorphic froglets to B. dendrobatidis 
 
B. dendrobatidis-free R. pipiens at 3-6 months post-metamorphosis were reared 
from eggs and were thus naïve to B. dendrobatidis.   Frogs were swabbed before the 
experiment to ensure they were B. dendrobatidis-free.  All 27 juveniles used in this 
experiment were negative.  The experiment consisted of four experimental groups: 1) 
Frogs injected with 40 nmol norepinephrine/g and again 2 days later with 20 nmol 
norepinephrine/g to deplete their granular glands and exposed to 10
4
 zoospores of isolate 
JEL275 (30) [N = 8];  2) Frogs injected with an equivalent volume of APBS and exposed 
to 10
4
 zoospores [N = 8];  3)  Frogs  injected with 40 nmol norepinephrine /g and again 2 
days later with 20 nmol norepinephrine/g and maintained as groups 1 and 2 without 
further manipulation [N = 3];  4) Frogs injected with APBS and maintained as groups 1-3 
without further manipulations [N = 8].  B. dendrobatidis exposure lasted for two days 
until the water on all frogs was changed and zoospores flushed out.  After exposure, the 
frogs were examined for signs for illness or death every day and swabbed at 10 days post 
exposure. 
 
Statistical comparisons 
 
Peptide concentrations, optical density determinations of B. dendrobatidis growth 
(OD490), relative peptide effectiveness, and zoospore equivalents determined by qPCR 
were averaged for each group, and the mean values ± standard errors (M ± SE) were 
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compared by one-way analysis of variance (ANOVA) after log transformation (Tukey 
post hoc test) or by Student’s t test following log transformation to meet the assumptions 
of normal distribution and homogeneity of variances for parametric statistics.  Percent 
survival of juveniles at 10 days post exposure to B. dendrobatidis was compared among 
experimental groups by a Chi-Square test.  A P value of  0.05 was considered 
statistically significant. The number of animals or replicates is shown in the figure 
legends.  
 
Results 
 
Determination of the dose of norepinephrine necessary to deplete skin peptide stores 
To determine the importance of AMPs in B. dendrobatidis infection, it was 
necessary to deplete the stores of AMPs in granular glands.  Prior to this study, the 
concentration necessary to fully deplete glands had not been determined.  With increasing 
concentrations of norepinephrine, greater concentrations of total peptides were recovered 
in a dose-dependent fashion.  The concentration required to maximally deplete peptides 
was 40 nmol norepinephrine/g (Fig. 3-1).  Although injection of 80 nmol 
norepinephrine/g induced slightly more peptides than the 40 nmol/g dose, the difference 
was not statistically significant.  
 
Renewal of depleted skin peptides 
In preparation for studies to determine the effects of skin peptide-depletion on 
susceptibility to experimental infections with B. dendrobatidis, it was important to 
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determine for how long peptide contents of granular glands remained depleted.  When 
peptides were depleted by one injection of 40 nmol norepinephrine/g, some residual 
peptides could be recovered at each time point tested, but peptide stores had not 
recovered to initial levels as late as 56 days after the first injection (Fig. 3-2A).  
Following one injection of 20 nmol norepinephrine/g, peptide stores were still 
significantly depleted until day 40 but recovered to initial levels after 50 days (Fig. 3-2B).  
To determine the effects of the norepinephrine-injection on gland morphology, histology 
was performed.  Dorsal skin sections were the most informative because animals were 
injected in an area adjacent to the complex of skin glands termed the dermal plicae (19).  
The morphology of intact glands is shown in a skin section from an APBS-injected frog.  
The glands are full of bright red granules by H&E staining (Fig. 3-2C).  In contrast, gland 
morphology following an injection with 40 nmol norepinephrine/g was quite different. 
The granular glands were empty of the eosinophilic granules, but they did not show 
significant structural damage (Fig. 3-2D).   
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Figure 3-1.  Dose-response to norepinephrine injections.  Frogs (N = 6 to 9 per group) 
were injected with APBS [N = 8] or 2 [N = 8], 20 [N = 6], 40 [N = 9] or 80 [N = 6] nmol 
norepinephrine/g. *All concentrations of norepinephrine induced more peptides than 
those recovered from APBS-injected frogs by one-way ANOVA after log transformation, 
Tukey post hoc test, P ≤0.01. Concentrations of peptides recovered from frogs injected 
with 2, 20, and 40 nmol norepinephrine/g were significantly different from each other 
and from APBS controls by one-way ANOVA after log transformation, Tukey post hoc 
test, P ≤0.05. 
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Figure 3-2.  Recovery of 
peptides following injection of 
norepinephrine.  (A) 40 nmol 
norepinephrine/g injected at 
each time point (N = 25 at day 
0; N = 4 or 5 at other time 
points).  *Peptide 
concentrations significantly 
reduced in comparison with 
those collected at day 0 by two-
tailed Student’s t-test after log 
transformation, p < 0.02.  (B) 
20 nmol norepinephrine/g 
injected at each time point (N = 
26 at day 0; N = 4 or 5 at other 
time points).  *Peptide 
concentrations significantly 
reduced in comparison with 
those collected at day 0 by two-
tailed Student’s t-test after log 
transformation, P < 0.025; 
**significantly reduced by one-
tailed Student’s t-test, P ≤ 0.05. 
(C)  Skin from APBS-injected 
control frog.  (D) Skin from 
frog injected with 40 nmol/g of 
norepinephrine showing intact 
but largely empty granular 
glands.  Granular glands are 
indicated with the letter “G”. 
significantly depleted until day 
40 but recovered to initial levels 
after 50 days (Fig. 3-2B). 
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Characterization of recovered peptides by MALDI-TOF mass spectrometry 
To determine whether the profile of AMPs that were newly synthesized following 
granular gland depletion was compositionally the same or different from the initial profile 
of peptides, peptides induced at days 0, 3, and 60 were compared by MALDI-TOF mass 
spectrometry.  Shown in Figure 3-3A are representative MALDI-TOF spectra.  The 
profiles are very similar to each other with the three expected brevinin peptides (brevinin-
1Pb, brevinin-1Pd, and brevinin-1Pa) present in order of relative intensity.  Also present 
is a strong signal for ranatuerin-2P and another defensive peptide, bradykinin (Fig. 3-3A).  
When comparing the activity of the recovered peptides from different time points, the 
ability to inhibit B. dendrobatidis growth was comparable between the initial peptides 
(Day 0, Fig. 3-3B) and the peptides recovered at other time points (Day 3 shown, Fig. 3-
3C).  Note that both sets of peptides showed a minimal inhibitory concentration (MIC) of 
about 50 µg/ml.  Given that the activity of peptides from day 0 and 3 were not different, 
peptides recovered at day 60 were not tested for growth inhibitory activity.   
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Figure 3-3.  Characterization of skin peptides recovered at days 0, 3, and 60 after 
norepinephrine induction.  (A) Representative MALDI-TOF profiles of peptides 
recovered after injection of 40 nmol norepinephrine/g at day 0 (top), day 3 (middle) and 
day 60 (bottom) (N = 5 frogs examined at each time point).  (B) Growth inhibition of B. 
dendrobatidis zoospores by peptides recovered at day 0 after norepinephrine injection. 
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(C) Growth inhibition of B. dendrobatidis zoospores by peptides recovered at day 3 after 
norepinephrine injection.  For (B, C), MIC = 50 μg/ml.  *Growth was significantly less 
than that of positive control wells by two-tailed Student’s t-test after log transformation, 
P ≤ 0.05 (5 replicates for each concentration of peptide, negative control, and positive 
control wells).  (D) Peptide effectiveness of the mixture of peptides recovered at day 0 
and day 3. Peptide effectiveness at day 3 was significantly decreased in comparison with 
that observed for peptides collected at day 0 by two-tailed Student’s t test after log 
transformation, P ≤ 0.05 (N =5 frogs sampled at day 0 and day 3). 
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Role of AMPs in protecting Rana pipiens juveniles 
Young postmetamorphic R. pipiens were used in these experiments because they 
had been reared in a laboratory free of the presence of B. dendrobatidis and were thus 
naïve to the pathogen.  MALDI-TOF analysis was performed on partially purified AMPs 
from these juvenile frogs to confirm that they have a normal complement of AMPs at this 
life stage.  Because the parents of these frogs were collected in the state of Minnesota or 
Wisconsin, the juvenile frogs expressed a slightly different profile of AMPs characteristic 
of populations in this region (178).  This profile includes brevinin-1Pa, brevinin-1Pb, 
brevinin-1Pe, and ranatuerin-2P (Fig. 3-4A).  The peptides recovered from the juvenile 
frogs showed excellent capacity to inhibit growth of B. dendrobatidis with an 
approximate MIC of 50-100 µg/ml (Range 25-250 µg/ml, M ± SE = 96 ± 27 µg/ml), 
comparable to that of peptides from adult frogs (Fig. 3-4B).  Next, the juvenile frogs were 
depleted of their peptides and experimentally infected (Fig 3-5A).When these 
postmetamorphic frogs were depleted of their peptides by two injections of 
norepinephrine and exposed to B. dendrobatidis in their water (NE+Bd), they did not 
survive as well as B. dendrobatidis-exposed animals which had an intact set of peptides  
(APBS+Bd).  Among the peptide-depleted and B. dendrobatidis-exposed frogs, only 3/8 
had survived to day 10 while 8/8 APBS-injected control frogs that were exposed to B. 
dendrobatidis were alive.  Other control groups that were norepinephrine-treated (3/3) or 
APBS-injected and not exposed to B. dendrobatidis (8/8) also survived to day 10 (Fig. 3-
5B).  Among frogs surviving at 10 days post-exposure to B. dendrobatidis, remaining 
peptide-depleted frogs had significantly higher numbers of zoospores on the skin than 
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APBS-injected and B. dendrobatidis-exposed frogs (Fig. 3-5C).  Frogs not exposed to B. 
dendrobatidis had no evidence of B. dendrobatidis infection determined by qPCR.  
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Figure 3-4.  Characterization of AMPs from postmetamorphic juveniles.  (A) 
Representative MALDI-TOF profile of hydrophobic skin peptides from juvenile frogs 
including antimicrobial peptides brevinin-1Pa, brevinin-1Pb, brevinin-1Pe, and 
ranatuerin-2P (representative of 12 individual frogs).  (B) Growth inhibition of B. 
dendrobatidis zoospores by skin peptides from juvenile frogs (representative of 12 
individual frogs tested). MIC = 50 μg/ml.  *Growth was significantly less than that of 
positive control wells by two-tailed Student’s t-test after log transformation, P ≤ 0.05 (5 
replicates for each concentration of peptide, negative control, and positive control wells). 
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Figure 3-5.  Peptide-depletion induced by norepinephrine increases susceptibility of 
postmetamorphic juveniles to B. dendrobatidis.  (A) The peptide-depletion and 
infection protocol is shown above.  Animals were housed individually and were infected 
by putting zoospores directly into their water.  (B) Percent survival of postmetamorphic 
juveniles peptide-depleted and exposed to B. dendrobatidis (NE+Bd, N = 8), APBS-
injected and exposed to B. dendrobatidis (APBS+Bd, N = 8), norepinephrine-injected but 
not exposed to B. dendrobatidis (NE, no Bd, N =3), or APBS injected but not exposed to 
B. dendrobatidis (APBS, no Bd, N =8).  Percent survival of peptide-depleted and B. 
dendrobatidis exposed frogs was significantly less than that of APBS-injected controls 
exposed or not exposed to B. dendrobatidis by Chi-Square test, P ≤ 0.05 and also 
significantly less than peptide-depleted frogs not exposed to B. dendrobatidis, P ≤ 0.1.  
(C) Infection intensity (zoospore equivalents + 1) on the skin of surviving frogs at day 10 
that were APBS-injected but not exposed to B. dendrobatidis (Bd) (APBS, no Bd, N = 8) 
or injected with norepinephrine (NE) and not exposed to Bd (NE, no Bd, N = 2) or APBS-
injected and exposed to Bd (APBS+ Bd, N = 7) or injected with NE and exposed to Bd 
(NE+Bd, N = 3).  The data represent the mean log zoospore equivalents + 1 ± standard 
error.  *Greater number of zoospore equivalents present on the skin of NE+Bd frogs 
compared to APBS+Bd frogs by a one-tailed Student’s t-test after log transformation, P = 
0.0352. 
 
A 
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Discussion 
The current study supports previous work that showed a correlation between the 
survival of amphibians exposed to B. dendrobatidis with beneficial AMPs (195,197,198).  
It also supports a previous study showing that depletion of skin peptides in Xenopus 
laevis (naturally resistant to chytridiomycosis) resulted in increased pathogen burden 
(144).   
 
Development of a method to deplete skin peptides 
 
Using adult northern leopard frogs (Rana pipiens) as a model, we developed a 
protocol to deplete skin AMPs by injection of norepinephrine and observed the relatively 
slow renewal of the same set of peptides over a period of approximately two months.  We 
then applied the same methods to deplete skin peptides from juvenile leopard frogs raised 
under laboratory conditions to insure that they were not exposed to B. dendrobatidis.  
This allowed us to examine the role of skin peptides in protection from B. dendrobatidis 
infections free of the potential complication of mucosal antibodies if the frogs had 
previously been exposed to B. dendrobatidis (144).  Although one injection of 40 nmol 
norepinephrine/g significantly reduced available skin peptides, some peptides were 
recovered at three days after the first injection.  We previously showed in X. laevis that 
two norepinephrine injections separated by two days were necessary to completely 
deplete skin peptides (62).  Thus, for the experimental infection study with juvenile R. 
pipiens, two norepinephrine injections were used.   
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Kinetics of peptide recovery and characteristics of the recovered peptides 
Previous studies of peptide recovery following norepinephrine injection examined 
relatively mild inductions, and recovery was examined after a very short time.  In 
Xenopus laevis, recovery of peptides following a mild norepinephrine injection (0.5 to 1 
nmol/g) was detected by fast atom bombardment mass spectrometry.  The full 
complement of expected peptides was detected within two to six days (68) suggesting 
that recovery is very rapid or peptides were not depleted by this injection.  Following 
injection of a slightly higher concentration of norepinephrine (3 nmol/g), gland 
morphology was not completely restored for two weeks as determined by histology and 
electron microscopy (53).  This suggested that a higher concentration of norepinephrine 
is necessary to more completely deplete peptides.  We have shown that in X. laevis, two 
injections of 80 nmol/g within two days were necessary to completely deplete peptides 
(62), and peptide recovery following depletion with 80 nmol/g required seven to nine 
weeks (144).  In the current study, we showed that peptide recovery after nearly complete 
depletion of R. pipiens peptides (injected with 40 nmol/g norepinephrine) required greater 
than 56 days (Fig. 3-2).  By MALDI-TOF MS analysis, the profile of recovered peptides 
at days 0, 3, and 60 were identical.  When concentrated, the peptides had similar growth 
inhibitory activity at days 0 and 3 (Fig. 3-3B and 3-3C).  This finding demonstrates that 
although the amount of AMPs present in the granular glands was reduced at day 3, the 
same relative mixture of peptides was present and effective against B. dendrobatidis.  
The relative effectiveness of the AMP mixture at day 3 versus day 0 showed that the 
relative effectiveness at day 3 was greatly diminished reflecting the reduced amounts of 
peptides that can be induced following their depletion three days earlier (Fig. 3-3D). 
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Immune defenses against B. dendrobatidis in juvenile frogs 
Our previous study of immune defenses against B. dendrobatidis in X. laevis, 
showed that both innate immune defenses (AMPs) and adaptive lymphocyte-mediated 
defenses play a role in protection of this highly resistant species (144).  The development 
of immune defenses in R. pipiens is not well studied, but we can make some informed 
assumptions about the maturation of the immune system based on studies of X. laevis.  In 
Xenopus, adult-type recognition of minor histocompatibility antigens and development of 
high affinity antibodies develops within 1-2 months post-metamorphosis 
(51,87,88,153,156).  Presence of high affinity IgY antibodies in Rana catesbeiana 
juveniles at 3 months post-metamorphosis (132) suggests that the adult B cell population 
in ranid frogs develops during the postmetamorphic lymphocyte expansion just as it does 
in Xenopus.  Thus, we are confident that the juvenile R. pipiens used in our studies at 3-6 
months post-metamorphosis had an adult-type immune system.  Much less is known 
about the ontogeny of expression of the antimicrobial peptide defenses.  However, 
previous studies in R. pipiens showed that granular glands are completely developed in 
the dermal plicae of R. pipiens at the conclusion of metamorphosis (19).  Thus, we 
assumed that the expected antimicrobial peptides would be present at 3-6 months post-
metamorphosis when the chytrid-exposure experiments were conducted.  To confirm that 
the AMP repertoire was complete, we examined the peptides present in twelve of these 
young frogs and found the expected AMPs in the majority of these animals (9/12) as 
shown in Fig. 3-4A.  Thus, the normal complement of AMPs had developed in these 
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young frogs, and the peptide depletion protocols developed in larger adults were effective 
in depleting the peptide reserves of the younger frogs. 
Although the most direct effect of injection of norepinephrine at the relatively 
high concentrations used in our experiments is the depletion of skin peptide reserves, the 
norepinephrine could also have other immunosuppressive effects such as activation of 
corticosterone release (166).  Future studies will determine whether there are other 
immunosuppressive effects of norepinephrine-treatment.  This very strong 
norepinephrine stimulus to deplete peptides was a pharmacological treatment to impair 
the skin peptide defenses.  It is unlikely that natural stresses in nature would result in 
such significant long-term depletion of skin peptides.  We showed previously (131) that 
the stress to a frog of being chased for ten minutes resulted in the total peptide release of 
about 6,400 µg of peptides/ml of mucus comparable to that observed following the 
injection of 2 nmol/g of norepinephrine in the experiments presented here (Fig. 3-1).  
Thus, the treatment to deplete peptides (40 nmol/g norepinephrine), which induced about 
90,000 µg of peptides/ml of mucus far exceeds the amount that would naturally be 
released. 
 
AMP protection of naïve juvenile frogs exposed to B. dendrobatidis 
Metamorphosis in amphibians is a time of fasting due to the extensive 
reorganization of the digestive tract (59).  In Xenopus, tadpoles are fasting after stage 62 
but their glucose levels in body fluids do not decrease (77).  As suggested by Jaudet and 
Hatey (95), glycogen, lipids, and proteins are probably converted to glucose (74,77).  
Elevation of corticosteroids hormones is observed during metamorphosis of all 
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amphibian species studied (49,97).  Therefore, it is likely that a tradeoff may occur that 
diverts energy from other physiological processes to the tissue and organ remodeling that 
occurs at metamorphosis because the organism has a finite amount of energy (115).  One 
of these systems affected is the immune system.  Wood frogs (Rana sylvatica) develop in 
temporary ponds, which may dry up in an unpredictable fashion.  In conditions that 
simulated quickly drying ponds, tadpoles metamorphosed earlier and appeared to 
experience a tradeoff in decreased total leukocyte counts and diminished cellular immune 
response (skin swelling in response to a plant lectin) (67).  Precocious metamorphosis 
induced by administration of thyroid hormones limited lymphocyte development and 
impaired allograft rejection responses in X. laevis (153).  During metamorphosis the 
immune system undergoes involution due to elevated corticosteroid hormones (156), and 
new metamorphs are particularly susceptible to diseases including chytridiomycosis 
(17,142,143,179,189).   
To assess the role of AMPS in protecting naïve juvenile frogs, froglets at 3-6 
months post-metamorphosis, which expressed a normal complement of AMPs capable of 
inhibiting growth of B. dendrobatidis at this life stage, were depleted of their peptides 
and exposed to a limited number of B. dendrobatidis zoospores.  Frogs that had their 
peptide stores intact survived the experimental infection significantly better than those 
that were peptide depleted (Fig 3-5B).  Peptide-depleted juveniles that survived the 
infection had significantly higher B. dendrobatidis zoospore loads compared to the 
peptide intact animals (Fig 3-5C).  In a previous study, we showed that AMPs are 
constitutively expressed by adult R. pipiens at low levels that are sufficient to inhibit B. 
dendrobatidis growth in vitro (131).  The current study demonstrates that those 
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constitutively released AMPs provide critical protection for the most susceptible life 
stage against B. dendrobatidis. 
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CHAPTER IV 
 
SWAB VS SOAK: THE BEST WAY TO DETECT B. DENDROBATIDIS 
 
Abstract 
 
 The chytrid fungus, Batrachochytrium dendrobatidis, has been linked to 
amphibian declines around the world.  Motile zoospores colonize the keratinized 
epithelium of adult frog and the mouth parts of tadpoles.  To further understand the 
magnitude and scope of this problem and determine pathogen burdens, effective testing 
for the pathogen is imperative.  The standard method for quantifying zoospore loads on 
infected amphibians is to swab animals on the most infected areas including the ventral 
abdomen, legs, and footpads.  Although this method is optimal for the field, the main 
drawback is that it does not take into account the zoospore load on the whole animal.  In 
this study a new method for testing amphibians was developed and compared to standard 
methods.  The new method includes a protocol in which frogs were submerged in sterile 
water for an hour, removed, and the water was filtered.  DNA was isolated from 
laboratory samples containing a known number of zoospores and live animals using the 
methods of filtration, swabbing, and centrifugation.  It was found that filtration was the 
most accurate method of detection. 
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Introduction 
Amphibians are facing serious declines from a fungal pathogen, B. dendrobatidis 
(10,134).  This pathogen, which causes the disease chytridiomycosis, has been identified 
in Africa, South America, Central America, North America, Europe, Australia, and Asia 
(10,17,111,122,189,190).  B. dendrobatidis has been detected in wild and captive 
populations including the amphibian orders of Anura, Caudata, and Gymophiona (133). 
The early testing for B. dendrobatidis involved highly invasive methods such as 
collecting toe clips (whole toes) or skins sections and performing histology using 
haemotoxylin and eosin staining (46).  Histological techniques have their own pitfalls.  
The problems with histological diagnosis are: 1) the investigator must develop the skills 
for accurate identification of the fungal cells within the skin; 2) the invasive nature of 
collecting toe clips from live animals; 3) the method is time consuming; 4) low 
sensitivity; and 5) there is variability in infection levels between different toes or skin 
sections (89).  
In B. dendrobatidis infection, early detection is imperative to allow for treatment 
and to prevent further spread within a captive colony.  Infected amphibians are frequently 
transported to new locations such as zoos, for the international pet trade, food trade, and 
the laboratory animal trade (118,122,130,134).  If detected early, amphibians can be 
treated and possibly cured.  It has been shown that simply by elevating body temperature 
B. dendrobatidis infection can be cleared (193).  Drug treatments have also shown to be 
effective (125). 
A PCR technique has been developed to more rapidly identify B. dendrobatidis 
infection.  This technique is quick, non-invasive, specific, and sensitive.  In fungal 
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ribosomal DNA, there are about 100-400 copies per haploid genome (113).  Fungal 
ribosomal DNA contains conserved regions of 5.8, 18, and 28S DNA interspersed with 
quickly evolving internal transcribed spacers and an intergenic spacer (113).  These 
characteristics were optimal for developing a real-time Taqman assay of B. dendrobatidis 
(20). 
The standard technique for testing a frog for B. dendrobatidis is to swab the 
abdomen, legs, and footpads 10 times each.  The DNA is isolated from the swab, and 
real-time PCR is performed.  This sampling method is optimized for the field.  
Researchers can catch the amphibians, swab them, and release the animal back into the 
wild in a matter of minutes.  The swabs are then able to be transported to the lab to be 
analyzed.  The method is quick and easy, but it does have its drawbacks.  First, swabbing 
methods are highly variable from person to person.  Second, it only measures the heavily 
infected areas of the frog and not the whole organism. 
One sampling method that does take into account B. dendrobatidis infection from 
the whole organism is the centrifuge method.  Here, frogs are placed in sterile water for 
an hour and removed.  The water is centrifuged and DNA isolation is performed on the 
pellet (89).  The pitfall to this technique is that B. dendrobatidis does not pellet well.  As 
a result, infection levels can be drastically underestimated compared to what is actually 
present on the frog. 
To solve the problems of both sampling methods, a new method was developed in 
our lab.  In the new sampling method, frogs were placed in sterile water, the water was 
then filter sterilized, and DNA was isolated from the filter.  This sampling method has the 
benefit of sampling from the entire frog, removing the variability from the swabbing 
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technique, and eliminating the pelleting problem.  In addition, the technique developed is 
able to be standardized and easily repeated in the laboratory setting.   
 In this chapter the newly developed technique was tested against the centrifuge 
and swabbing method.  Factors considered included accuracy against known standards 
and zoospore load detected.  It was hypothesized that the filtration method is a better 
measure of quantifying infection load compared to the standard methods of B. 
dendrobatidis sampling. 
 
Materials and Methods 
 
Frogs 
Adult Rana pipiens measuring between 2 and 2.5 inches were purchased from 
Connecticut Valley Biological (Southampton, MA).  Frogs were housed in groups of 5 to 
6 in covered polystyrene containers in dechlorinated tap water at a temperature of 20-
24°C.  Containers were placed at an angle allowing the animals to choose between a wet 
or dry environment.  They were fed live crickets, and water was changed three times a 
week.  All protocols used were approved by the Vanderbilt University Medical Center 
Institutional Animal Care and Use Committee. 
 
Culturing B. dendrobatidis 
 
 B. dendrobatidis isolate JEL 197 was cultured on tryptone agar plates.  Zoospores 
were isolated > 95% purity by filtration over sterile nylon spectramesh filters as 
previously described (Chapter II).  Zoospores were stained with Lugol’s solution and 
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counted using a hemocytometer.  Zoospores were diluted to a concentration of 10
2
, 10
3
, 
10
4
, 10
5
 and 10
6
 zoospores total in a volume of 50 ml. 
 
Swabbing of B. dendrobatidis 
 
 B. dendrobatidis standards with a known number of zoospores (3 µl) were loaded 
onto swabs.  Frogs were rinsed with deionized sterile water to remove any dead zoospore 
DNA.  Animals were then swabbed on the ventral abdomen 10 times, legs 10 times, and 
footpads 10 times.  DNA was isolated from the swabs according to the method of Boyle 
et al., (20) by putting the swabs in 60 µl of PrepMan Ultra (Applied Biosystems, Foster 
City, CA) and 30 to 35 mg of zirconium/silica beads (0.5 mm in diameter)(Biospec 
Products, Bartlesville, OK).  Swabs were homogenized in a Mini Beadbeater (MP Bio, 
Solon, OH) for 45 seconds followed by a 30 second centrifugation at 15,000 x g.  
Homogenization and centrifugation were repeated once more.  Samples were then boiled 
for 10 minutes, and cooled for 2 minutes room temperature, and centrifuged for 3 minutes 
at 15,000 x g.  Supernatants containing B. dendrobatidis DNA were removed for real-
time PCR. 
 
Centrifugation of B. dendrobatidis 
 
 B. dendrobatidis standards with a known number of purified zoospores were 
centrifuged for 20 minutes at 3,000 rpm.  Supernatants were removed and the pellet was 
resuspended with 200 µl or PrepMan Ultra (Applied Biosystems, Foster City, CA), and 
DNA was isolated as described above. 
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Filtration of B. dendrobatidis 
 
 B. dendrobatidis standards with a known number of purified zoospores were 
filtered through a 0.22 micron filter.  Following filtration, the filters were submerged into 
a solution containing 200 µl of PrepMan Ultra (Applied Biosystems, Foster City, CA) 
and 50 mg of zirconium/silica beads (0.5 mm in diameter)(Biospec Products, Bartlesville, 
OK).  After this step the protocol for DNA isolation was identical to the swabbing 
protocol.  For live animals, frogs were rinsed with sterile deionized water to remove any 
dead B. dendrobatidis DNA.  Animals were then placed in 100 ml of sterile dechlorinated 
water for 1 hour, the water was filtered through a 0.22 micron filter, and DNA was 
isolated as described above. 
 
B. dendrobatidis real-time PCR 
 Probe-based real-time PCR was performed on the Mx3000P Real-Time PCR 
system (Stratagene, La Jolla, CA) according to the protocol of Boyle et al. (20).  The 
standard PCR cycles were as follows: 95°C for 10 minutes, then 95°C for 30 seconds, 
55°C for 1 minute and 72°C for 1 minute for 40 cycles according to previous protocol 
(20,89).  The number of zoospore equivalents was calculated based on a standard curve 
of threshold values from control zoospore DNA. 
 
Statistical comparisons 
 All parameters compared were averaged, and plotted with standard error bars.  
The means were compared by one-tailed or two tailed Student’s t test.  A P value of less 
than 0.05 was considered statistically significant.   
 80 
Results 
 
Filtration vs centrifugation 
 Known standards containing 10
2
, 10
3
, 10
4
, and 10
6
 zoospores were made in sterile 
deionized water.  DNA was isolated, and real-time PCR was performed to assess 
accuracy and detection limits and centrifuged or filtered.  The filtration method was much 
more accurate and sensitive than the centrifuge method.  For all standards the filtration 
method detected more zoospore equivalents, and the numbers detected were within 1 log 
of the input zoospore numbers.  The centrifugation method did detect B. dendrobatidis 
DNA, but numbers of zoospores detected was often much lower than the input number of 
zoospores (Fig 4-1).  
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Figure 4-1.  Comparison of the filtration and centrifugation methods with known 
zoospore inputs.  Zoospore inputs of 10
2
, 10
3
,10
4
, and 10
6
 were compared between the 
two methods.  The number of zoospores detected was log transformed and tested for 
significance using a Student’s two-tailed t-test. 
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Filtration vs swabbing 
 
 Next the filtration method was compare to the swabbing method in terms of 
ability to recover and quantify zoospore DNA.  Standards with a known number of 
zoospores were applied to filters or swabs which were subjected to DNA isolation.  In 
this comparison, the swabs and filters were roughly equivalent with less than a 1 log 
difference between them in numbers of zoospores detected (Fig 4-2). 
 
Filtration vs swabbing using naturally infected animals 
 The filtration and swabbing methods were tested on naturally infected live 
animals.  Although there was no difference when known numbers of zoospores were 
applied to filters or swabs, there was a profound difference in zoospores detected from 
live animals.  Animals were grouped according to their infection status based on the 
standard swabbing method.  Frogs with less than 100 zoospores were considered to have 
mild infections.  Frogs with 100-10,000 zoospores were considered moderately infected, 
and frogs with more than 10,000 zoospores were considered severely infected.  At the 
lower infection levels the filtration method detected more zoospore DNA than the swab 
method (Fig 4-3). 
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Figure 4-2.  Comparison of the swabbing and filtration methods with known 
zoospore inputs.  Zoospore inputs of 10
1
, 10
2
,10
3
,10
4
, 10
5
 and 10
6
 were compared 
between the two methods.  The number of zoospores detected was log transformed and 
tested for significance using a Student’s two tailed t-test. 
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Figure 4-3.  Comparison of swabbing and filtration methods in naturally infected 
animals.  Animals were grouped into mild (< 100 zsp), moderate (100< 10,000 zsp), and 
severe (> 10,000 zsp) by the zoospore equivalents from the swabs.  N =  3-9 frogs per 
group.  The amount of zoospores detected was log transformed and tested for significance 
using a two-tailed Student’s t-test. 
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Discussion 
 As B. dendrobatidis continues to spread globally, it is important to monitor its 
prevalence in wild and captive populations.  Although the creation of a B. dendrobatidis 
probe-based real-time PCR assay played a critical role in identifying infected individuals, 
swabbing may not be giving a complete picture of infection status (20).  The new method 
proposed based on sampling B. dendrobatidis from frogs by soaking them and filtering 
their water improves upon the two traditional methods of centrifugation of soak water 
and swabbing. 
 In Figure 4-1, known input numbers of B. dendrobatidis zoospores were put 
through either the filter sampling method or the centrifugation sampling method.  Both of 
these techniques sample the entire frog by isolating zoospores washed off from the skin 
and concentrated by either filtration or centrifugation.   The filtration sample method 
outperformed the centrifugation sample method be detecting more zoospore DNA and 
being closer to the original input of zoospores.  It is suspected that the filtration method 
performed better because B. dendrobatidis zoospores do not pellet well and some of the 
input may have been lost while removing the supernatant. 
Next the filtration sampling method was tested against the swabbing method in 
vitro (Fig 4-2).  Here, the swabbing method and the filtration method tested similarly and 
were within 1 log of each other in terms of zoospore equivalents.  Although there was no 
real difference between the sampling methods, it was thought that there would be a 
difference when sampling live animals because swabbing only samples particular parts of 
the frog while filtration would sample the whole frog. 
 In Fig 4-3, the swab sample method and filtration sample method were tested on 
 86 
naturally infected adult R. pipiens.   For each animal the amount of zoospore DNA 
detected by the filter was higher compared to that of the swab.  When grouped by 
infection loads, there were significant differences between the filtration and swab 
collection methods.  It is thought that sampling the whole frog compared to the select 
areas of swabbing led to these differences. 
 The swab method of sampling will remain the main method of sampling B. 
dendrobatidis in the wild. It offers the advantages of being quick, easy, and transportable.  
We suggest that for laboratory studies and for other animals in captivity the filter method 
may lead to a more accurate picture of infection status by sampling the entire animal.  
Swabbing is highly variable by each person performing the sampling method.  Filtration 
removes this variable by soaking the frog in a specific volume of sterile water. Another 
benefit is that it can be standardized and the data generated by this sampling method 
could be compared to data generated by other groups and in different species.  As a more 
accurate test for infection, filtration could be performed and the necessary steps could be 
taken to cure infected animals. 
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CHAPTER V 
 
DISCUSSION AND FUTURE DIRECTIONS 
 My dissertation is the first work to specifically examine the dynamics of 
antimicrobial peptide (AMP) defenses and their role in the immune defense against 
Batrachoychytrium dendrobatidis.  It has long been known that AMPs produced in 
amphibian skin have in vitro activity against a whole range of pathogens, but it was 
unclear if they played a role in the protection of the frog.  This work suggests that AMPs 
play a critical role in protecting frogs against the often lethal skin pathogen, B. 
dendrobatidis, at several life stages.  A better understanding of the innate defenses of 
wild amphibians will aid conservation efforts. 
 
The ebb and flow of antimicrobial peptides on the skin of Rana pipiens 
 R. pipiens populates much of North America and has been shown to have a suite 
of peptides active against many pathogens.  It was hypothesized that if these AMPs were 
expressed, they would be quickly degraded by proteases and would not be able to prevent 
pathogen infection.  Using a very sensitive technique, direct MALDI-TOF MS, individual 
AMPs were detected on resting and chased frogs without inducing AMP secretion by 
norepinephrine injection.  When the secretions were tested for anti-B. dendrobatidis 
activity using growth inhibition assays, the peptides recovered from resting and chased 
frogs were able to inhibit the growth of B. dendrobatidis, albeit less effectively than those 
from norepinephrine-induced animals, suggesting that the AMPs do play a role in 
immunity against skin pathogens. 
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 Another major question that was answered by my studies is what happens to 
AMPs following secretion.  To induce peptide secretion, frogs were injected with 
norepinephrine.  The secretions were allowed to remain on the skin for various periods of 
time before being washed off the skin.  The total amount of peptides recovered decreased 
in a time-dependent manner.  Secretions also had decreased anti-B. dendrobatidis activity 
over time.  To examine the relative quantification of individual AMPs over time, I 
developed a method in which an alkylated form of one of the native AMPs was added to 
the peptide mixtures at a known concentration.  The relative intensities were compared to 
the external standard and revealed that individual AMP signal intensities also decreased 
in a time-dependent fashion. 
 It was hypothesized that the AMPs were being degraded by a protease.  In another 
frog species, X. laevis, an endoprotease was found that cleaved at an amino acid position 
preceding lysine residues.  In secretions from resting and chased animals at the later time 
points, AMP fragments were found which matched such predicted cleavage products.  
Taken together this work suggests that AMPs are expressed constitutively at low levels 
and have anti-B. dendrobatidis activity at these concentrations.  After secretion onto on 
the skin, they are broken down by an endopeptidase present in the same skin secretions. 
 
Skin peptides protect juvenile leopard frogs from chytridiomycosis 
 During metamorphosis, the immune system is suppressed and much of the frog’s 
energy is put into the process of tissue remodeling.  R. pipiens is thought to be a species 
that is relatively resistant to chytridiomycosis.  In the studies described in chapter III, the 
goal was to determine the role of AMPs in defense against B. dendrobatidis of recently 
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metamorphosed juvenile frogs.  To do so, a skin peptide depletion protocol was 
established using increasing doses of norepinephrine.  It was determined that peptide 
secretion was maximal at 40 nmol/g.   
To determine how long skin peptides would remain at low levels, frogs were then 
injected with a depleting dose and injected again at various later time points.  AMPs had 
not yet recovered to initial levels at 56 days after depletion with 40 nmol/g, but were able 
to recover in about 50 days after injection with a 20 nmol/g dose.  This demonstrates that 
the peptide-depletion protocol resulted in a long-term depletion of this important skin 
defense.  The suite of recovered AMPs was identical to the initial peptides, and their 
activity in anti-B. dendrobatidis growth inhibition assays was the same. 
Lastly, B. dendrobatidis naïve R. pipiens at 3-6 months after metamorphosis were 
depleted of their peptides and exposed to infectious B. dendrobatidis zoospores to truly 
test the role AMPs as a deterrent to B. dendrobatidis infection.  Individuals that were 
infected and peptide-depleted died rapidly compared the three other control groups.  In 
addition, they had higher B. dendrobatidis loads compared to the controls.  This 
experiment suggests that AMPs provide some degree of protection against 
chytridiomycosis. 
 
Swab vs soak: The best way to detect B. dendrobatidis 
 In the field, frogs are caught and sampled by swabbing the most infected areas of 
the frog, the abdomen, legs, and footpads.  While sampling these areas can give a quick 
yes or no determination of infection and such sampling has been used to quantify 
intensity of infection, it can be misleading because the method does not sample the entire 
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animal.  Although it is acknowledged that this method is optimal for the field, there may 
be better methods for use in the laboratory setting.  In chapter IV, a method was 
described in which frogs were submerged in sterile water, removed, and water was 
filtered.  B. dendrobatidis DNA was then isolated from the filter and B. dendrobatidis 
load was quantified using real-time PCR. 
 The method developed in this chapter is the first to accurately test zoospore load 
by sampling the entire organism and removing variability due to differences in the 
swabbing technique of different investigators.  The filtration method also helps to 
standardize B. dendrobatidis sampling by using defined volumes and soak times.  This 
method is proposed for use in laboratory studies but would be cumbersome in the field 
studies because of the need to haul more equipment and delay the release of the animals 
into their habitat. 
 
Future Studies 
 My work showed that antimicrobial skin peptides may be very important for 
protection of newly metamorphosed juvenile frogs from B. dendrobatidis infection.  
However, little is known about the ontogeny of expression of AMPs at the time of 
metamorphosis.  Future studies will demonstrate whether the granular glands are fully 
differentiated at the time of metamorphosis or require several weeks or month to develop.  
MALDI-TOF analysis of skin secretions will demonstrate whether the full repertoire of 
expected AMPs is present at metamorphosis or takes weeks or months to develop.  
Answers to these questions will more fully define how vulnerable metamorphosing frogs 
are to chytridiomycosis. 
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 My work showed that individual AMPs can be detected in the mucus of resting 
and chased frogs by direct MALDI-TOF.  However, we do not yet have a good measure 
of the actual concentrations of individual peptides in the mucus of these minimally 
manipulated frogs.  Future studies are planned to use direct skin sampling coupled with 
addition of a known concentration of an external peptide to more rigorously quantify the 
relative concentration of individual AMPs using MALDI-TOF MS and related methods.  
 AMPs have been shown to have activity against many bacterial species.  In this 
thesis, it was shown that AMPs are expressed constitutively at low levels and when left 
on the skin, the AMPs are degraded in a time-dependent fashion.  It is thought that the 
AMPs are degraded to protect the microbiota present on the skin or to protect the 
integrity of the skin itself.  It has been shown that amphibians harbor bacterial species 
that secrete metabolites capable of inhibiting B. dendrobatidis growth (26,78,199).  The 
interplay between these two innate defense mechanisms should be further examined. 
 Work currently being done in the Rollins-Smith lab is to identify bacterial isolates 
present on the skin of ranid frogs.  Bacterial isolates have been grown up and 
supernatants were tested for anti-B. dendrobatidis activity.  Current experiments are 
being performed to see if there is synergy between the AMPs and bacterial supernatants.  
It is thought that the presence of both may provide a more effective defense against B. 
dendrobatidis infection. 
 AMPs from amphibians have been shown to have activity against a wide range of 
pathogens in vitro (203).  Further studies of amphibian AMPs such as membrane binding, 
mechanism of action, intracellular effects may lead to the use of these peptides as 
therapeutic agents (64,102).  For example, the AMP buforin IIb has been shown to have 
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antitumor activity in P53-deficient mice (34).  Furthermore, amphibian AMPs have been 
shown to have anti-parasite properties showing activity against the causative agents of 
malaria and Chagas’ disease (147).  Lastly amphibian AMPs have activity against HIV 
and the transfer of the virus from dendritic cells to T cells (182). 
 There is considerable controversy about the use of AMPs for prevention or cure 
of infections (169).  Many AMPs have toxic properties when administered in high doses 
because of their non-specific binding and membrane disruption properties.  Efforts have 
been made to synthetically modify AMPs to maintain antimicrobial activity but reduce 
protease, and hemolytic activity. 
 Specific modifications to improve AMP function and limit toxicity are using 
truncated forms of the peptides and the use of peptides containing only D-amino acids to 
limit protease activity.  Another modification shown to improve AMPs is using poly-N-
substituted glycines (peptoids) that are attached to the amide nitrogen instead of the α-
carbon.  This change has been shown to have good antibacterial activity but low 
hemolytic activity (35).  Other modifications, such as using β-peptides, arylamide 
oligomers, and phenylene ethynylenes, have shown similar results (158). 
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